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ABSTRACT
The underlying causes of major mental illness are not understood and diagnoses
are made largely on the basis of characteristic clinical symptoms described by the
patient. A long-standing aim of biological psychiatry is to identify clinical
measurements related to illness that may assist in diagnosis in the same way that
the measurement of blood glucose level is used in the diagnosis of diabetes. In
genetic studies such biological markers of disease have been termed
"endophenotypes". Neuropsychological impairments are well described in
schizophrenia and bipolar disorder. This study investigates a possible role of
specific neuropsychological impairments as markers and "endophenotypes" of
illness. The aims of the present study were to (a) confirm previous findings in
schizophrenia and bipolar affective disorder of selected cognitive impairments and
effects of clinical state and medication, and (b) to establish whether members of a
large family multiply affected with bipolar and unipolar affective disorder showing
linkage to a chromosome 4 locus, show changes similar to the population group of
bipolar and unipolar patients.
Groups of forty-one unipolar affective disorder patients, thirty-seven bipolar
affective disorder patients, twenty-six schizophrenic patients, fifteen high risk
family members and thirty-one healthy controls were assessed with a
neuropsychological test battery focussing mainly on the domains of memory and
executive function. Bipolar and schizophrenic patients had similar impairments of
verbal learning and memory relative to controls. Schizophrenic patients were also
4
impaired on executive function tasks. Performance was not due to symptom
severity or medication. There were no significant differences between unipolar
affective disorder patients and controls. The second major finding from this work
is that cognitive deficits were measured in relatives in one family who were at high
genetic risk of developing bipolar disorder but who had not developed symptoms
of the disorder. It can be concluded that these cognitive deficits may be considered
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1.0 GENERAL INTRODUCTION
The underlying causes of the major mental illnesses including affective disorders
and schizophrenia remain largely unknown and their definition and classification is
essentially descriptive. Major mental disorders are diagnosed on the basis of
symptoms described by the patient and no established biological markers are
available to contribute to diagnosis. Structured interviews and standardised
diagnostic criteria such as ICD-10 (World Health Organization 1992) and DSM-IV
(American Psychiatric Association, 1994) have improved reliability of diagnoses
but their validity remains uncertain. These diagnoses are operational definitions
and according to Mechanic (1999) are neither theoretically grounded nor
biologically validated. An emerging feature of schizophrenia and bipolar affective
disorder research is underlying cognitive dysfunction and a clearer understanding
of cognitive impairment, and indeed other abnormalities, in these disorders could
improve knowledge of their biological causes and provide a basis for classification.
Neuropsychology is important in studies of psychosis for a number of reasons.
Firstly, correct definition of patients' cognitive deficits will aid interventions and
rehabilitation, giving neuropsychological assessment a role in patient management.
Furthermore, neuropsychology has a role in diagnosis, for example distinguishing
dementia from depression or identifying subgroups of depression. Finally,
neuropsychological studies can lead to further understanding of the pathology of
psychosis and its genetic basis. This thesis focuses on the second two points. The
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main questions it attempts to address are: (1) do the cognitive deficits found in
schizophrenia, unipolar depression and bipolar affective disorder differ? (2) Can
neuropsychological impairments be measured in high risk unaffected relatives of
probands and will testing learning and memory be useful in unravelling the genetic
basis ofmajor mental illness?
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2.0 SCHIZOPHRENIA
2.1 Definition of Schizophrenia
The diagnosis of schizophrenia is based on the presence or absence of a number of
characteristic clinical symptoms that include disorders of thinking, beliefs,
perceptions, mood, and movement. No symptoms are exclusive to schizophrenia
and there is an overlap with psychotic states associated with affective illness,
stimulant drugs and organic brain pathology. The aetiology of schizophrenia is
poorly understood and there are no objective tests so the diagnosis of the disorder
relies upon clinical symptoms and outcome. It may be the case that the current
diagnosis of schizophrenia encompasses a group of disorders having a similar
course of illness which includes a tendency towards onset in adolescence or early
adulthood, recurrent psychotic episodes and deterioration in social and
occupational functioning (Johnstone, 1998).
Schizophrenia is a devastating disorder affecting around one in a hundred people in
the general population and diagnosis is usually based on one of two classification
schemes, the Diagnostic and Statistical Manual for Mental Disorders (DSM-IV,
1994) of the American Psychiatric Association or the International Classification
ofDiseases (ICD-10, 1992) of the World health Organisation.
Towards the end of the nineteenth century, Kraepelin (1896/1987) proposed a
simplified classification scheme for psychoses. Schizophrenia, termed "dementia
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praecox" was distinguished from two other kinds of psychosis manic depressive
and organic psychoses. The organic psychosis best described at that time was
Alzheimer's disease with its characteristic neuropathology. No such characteristic
neuropathology had been demonstrated in dementia praecox so it was therefore
deemed a 'functional' as opposed to an organic condition. Within the functional
psychoses, Kraepelin demarcated dementia praecox from manic-depressive
psychosis through symptoms and course of illness. Dementia praecox was marked
by decline with no recovery, whereas manic-depressive psychosis was
characterised by alternating periods of illness and normality.
Bleuler (1908/1987) devised a different classification scheme, which placed greater
emphasis on the psychological bases for schizophrenic symptoms. It was Bleuler
who coined the term 'schizophrenia' in an effort to encompass his concept of the
splitting apart of different mental faculties. In this sense, 'incongruity of affect'
implies that emotion and understanding are no longer properly linked.
It is important to note that we only know about patients' bizarre experiences and
beliefs because the patients themselves speak of them, hence they are known as
symptoms. There are also abnormalities in behaviour that can be observed, known
as signs. These can be broadly classified into two groups, positive and negative
symptoms and signs. Positive symptoms are delusions and hallucinations that are
abnormal by their presence. Negative symptoms including loss of motivation,
poverty of action or alogia are known as such because they represent an absence of
behaviours present in normal people. As the illness progresses it is often the case
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that the bizarre experiences and beliefs that initially lead to diagnosis become less
evident and only so-called negative symptoms are present.
The DSM-IV criteria for schizophrenia are as follows:
The patient must have
A) characteristic psychotic symptoms for at least one week
B) social functioning below previous levels during the disturbance
C) no major changes in mood (depression or elation)
D) continuous signs of the disturbance for at least 6 months
E) no evidence of organic factors (e.g. drugs)
Characteristic psychotic symptoms must include





flat or grossly inappropriate affect
OR 2) bizarre delusions (e.g. thought broadcasting)
OR 3) prominent hallucinations of a voice with content unrelated to mood
The risk of developing schizophrenia seems to be largely independent of culture or
socio-economic status. In men, the mean age of onset is in the early to mid-
twenties but the disorder can be apparent in children as young as eight and
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schizophrenic symptoms can be observed for the first time in the elderly.
Schizophrenia is equally common in women although with an average slightly later
age at onset in the mid-thirties (Hafner et al. 1989). The cause of schizophrenia
remains unknown but it is generally assumed to have an organic basis because of
neuropathology and neuroimaging findings (Zipursky et al. 1994; Bruton et al.
1990). There is strong evidence for a genetic component in the aetiology in
schizophrenia and also some evidence for increased risk though birth injury or
prenatal viral infection. There is no evidence that psychosocial factors directly
cause schizophrenia but these may be precipitating factors or lead to relapse in
those individuals who are already at risk, either through genetic or environmental
factors or a combination of both. (Johnstone 1998)
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2.2 Genetic Aspects of Schizophrenia
There is overwhelming evidence that genetic factors play an important part in the
aetiology of schizophrenia. The illness has long been observed to "run in families"
(Nurnberger and Berrettini 1998). Gottesman and Shields (1982) have shown from
pooled European family study data that the age-corrected morbid risk of
developing schizophrenia is 5.6% in parents, 10.1% in siblings and 12.8% in
children of schizophrenics. It is suggested that the lower risk in parents compared
to offspring is related to a relative decrease in fertility among schizophrenic
patients. The morbid risk for schizophrenia in the general population is around one
percent, so these figures show that all classes of first-degree relatives have
increased risk of developing the disorder. However, family studies do not
distinguish between shared genes and shared environment. This can be done by
twin and adoption studies.
Twin studies in schizophrenia have repeatedly shown that monozygotic (MZ) twin
concordance is greater than dizygotic (DZ) twin concordance, which is consistent
with a genetic susceptibility. Nurnberger and Berrettini (1998) have summarised
twin studies and calculated total concordance rates of 33% for MZ twins and 8%
for DZ twins for strictly defined schizophrenia and MZ concordance rates of 49%
and DZ concordance rates of 9% in more broadly defined schizophrenia. Kendler
and Robinette (1983) have argued that the heritability of schizophrenia is around
70%, meaning that 70% of the variance in incidence of schizophrenia in the
population is accounted for by genetic factors. However, Nurnberger and
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Berrettini (1998) calculate the heritability to be around 44%, although using a
different statistical method. Overall, it would seem that the heritability is
considerable, as are the influence of non-genetic factors.
Adoption studies were first used to investigate schizophrenia by Heston (1966)
who found increased incidence of schizophrenia in the adopted-away offspring of
women with schizophrenia compared to control adoptees. Kety et al. (1983)
conducted a large systematic review of studies in which adoptees were separated
from their biological parents at an early age and adopted by non-relatives. The
review revealed that there were more cases of schizophrenia and schizophrenia
spectrum disorders in the biological relatives of schizophrenic adoptees than in the
biological relatives of psychiatrically normal adoptees.
Recently, genetic linkage studies have identified several chromosome regions of
interest. For example a disrupted brain expressed gene DISC 1 on the long arm of
chromosome 1 has been described as segregating in a large family with
schizophrenia and other major psychiatric disorders and may be one of several or
many genes implicated in this complex disorder (Blackwood 2001; Millar 2000).
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2.3 Imaging in Schizophrenia
Beginning with Pinel (1801) and later Kretschmer (1925) (both cited in Shenton et
al. 2001), there has been an interest in brain and cranium size in mental illness,
based on a presumed association between this and mental illness, socio-economic
status, IQ and cognitive deficits.
After more than one hundred years of research, the neuropathology of
schizophrenia remains controversial. Both Kraepelin (1896/1987) and Bleuler
(1908/1987) were convinced that it would ultimately be linked to an organic brain
disorder. A great deal of progress has since been made in neuroimaging, especially
since the advent of magnetic resonance imaging (MRI) techniques, which have
confirmed the presence of brain abnormalities in schizophrenia. The major
findings include ventricular enlargement and the preferential involvement of the
medial temporal structures including the amygdala, hippocampus and frontal
cortical regions including the dorso-lateral prefrontal cortex. Many brain areas
have been implicated in schizophrenia, and this is evident from studies that have
found abnormalities in the parietal lobes, subcortical structures including the basal
ganglia, corpus callosum and thalamus, and also the cerebellum (summarised by
Ebmeier 1995). What these MRi studies have not been able to ascertain is the
timing of the onset of these abnormalities although many are evident when the
patient first becomes symptomatic. There is also some evidence that brain
abnormalities may change over time. The most parsimonious explanation is that
some abnormalities are neurodevelopmental in origin but their clinical
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consequences unfold later in development, producing schizophrenia symptoms.
However, there may be other factors such as stress or neurotoxicity that occur
during adolescence or early adulthood and are necessary for the development of
schizophrenia and may be associated with neurodegenerative changes. As Shenton
et al. (2001) have stated, new models are needed to explain neural circuitry
abnormalities affecting brain regions, which are not necessarily structurally
proximal to each other but are nonetheless functionally interrelated, since so many
brain regions appear to be involved in schizophrenia.
2.4 Neuropsychology of Schizophrenia
2.4.1 Why study neuropsychological function?
There are several important reasons for studying neuropsychological function in
patients with psychiatric disorders. It is contended that people who suffer from
psychiatric illnesses interpret the information they receive from their sensory
systems incorrectly and consequently their behaviour is affected by responding to
this distorted reality. People with psychiatric illnesses do not generally appear to
have had greatly dissimilar life experiences from those of psychiatrically 'normal'
people, so there must be something different about the way in which they process
this distorted reality that distinguishes them from unaffected people.
Neuropsychological data can inform the diagnostic process by distinguishing
between different psychiatric disorders. An explanation, when evidence based,
that illness may affect cognitive functions such as memory can be reassuring to
patients suffering anxiety and self-doubt. It has been demonstrated that defects in
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motivation and in abilities to plan, organise and carry out activities along with
problems of self-monitoring can severely compromise patients' capacities to live
independently (Green 1996) and neuropsychological assessment may contribute to
patient management.
Much of the literature investigating the neuropsychological consequences of
psychiatric disorders is essentially atheoretical as so little is known about the
connection between psychiatric symptoms and neuropsychological dysfunction.
Crowe (1998) has stressed the importance of investigating neuropsychological
function to find similarities or differences between psychiatric disorders as an aid
to understand aetiology and in the attempt to investigate whether
neuropsychological dysfunction may be a biological marker of illness.
2.4.2 Why memory and executive function?
Lezak (1995) states that behaviour can be conceptualised in terms of three
functional systems: (1) cognition, which is the information-handling aspect of
behaviour; (2) emotionality, concerning feelings and motivation; and (3) executive
functions, concerning how behaviour is expressed. Psychiatric disorders usually
affect all three systems. Memory and executive function are the focus of this work
because these are central to all cognitive functions (Lezak 1995). Memory
impairment has severe implications for social and intellectual functioning.
Executive functions enable people to engage in independent, purposeful, self-
serving behaviour. Impaired executive function reduces the capacity for self-care,
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for independent work and maintaining normal social relationships regardless of the
level of cognitive capacities. Executive dysfunction can be observed globally,
affecting all aspects of behaviour, or can be demonstrated in impaired strategies in
planning or carrying out cognitive tasks, or poor self-monitoring. Thus,
investigations of these aspects of neuropsychological function can inform our
understanding of the pathology of psychiatric illness and its genetic basis, and have
implications for outcome and management.
The investigation of neuropsychological outcome in schizophrenia is not merely an
academic pursuit as cognitive impairment can have severe real-life consequences.
Green (1996) conducted a review of studies using cognitive measures as predictors
or correlates of functional outcome and uncovered some interesting findings.
Verbal memory functioning appeared to be associated with all types of functional
outcome and sustained attention and vigilance also related to social problem-
solving and skill acquisition. Interestingly, psychotic symptoms were not
significantly associated with outcome measures. Green therefore concluded that
verbal memory and vigilance deficiencies prevent optimal adaptation and are thus
rate-limiting factors in rehabilitation terms. These may be the central and enduring
features of the illness, rather than psychoticism. Addington and Addington (1999)
demonstrated that in schizophrenic patients, better cognitive flexibility and verbal
memory was positively associated with greater interpersonal problem-solving
ability. This evidence does therefore suggest that cognitive impairment in
schizophrenia is directly related to social deficits and functional outcome.
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2.4.3 Background to the review
The aim of this work is not to attempt to localise function in the brain. Benton
(1981) asserts that symptoms should be interpreted as expressions of disturbance in
a system and not as a direct expression of focal loss of neuronal tissue. A number
of lesions can produce disruption in functions such as memory or executive
function. These lesions may be widely distributed throughout the brain. The
neuropsychological impairment only indicates that the distributed network
involved in that particular function has been disrupted and the symptom itself gives
little information about specific localisation. Luria (1973) states that each
neuropsychological function is effected by a complex functional system
incorporating a number of factors dependent upon the combined working of a
number of cortical zones and subcortical structures, each making its own
contribution to the performance of the function. The review of the literature will
focus on empirical findings, meaning that an attempt will be made to clarify
whether neuropsychological impairments occur in schizophrenia or not, rather than
attempting to review in detail any theoretical models linking symptoms or anatomy
with deficits as these are premature due to the current level of knowledge.
However, attempts will be made where possible to describe any impairment in
terms of a disruption of normal cognitive processes (Halligan and David 2001).
The following review of the literature of cognitive impairment in schizophrenia
places particular emphasis on the domains of memory and executive function,
which are the focus of this thesis.
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2.4.4 General cognitive function
In an early monograph, Bleuler (1913/1950) asserted that intelligence and general
cognitive function remained intact in schizophrenia, a view which was still
accepted until fairly recently. It was accepted that schizophrenia sufferers
performed poorly on intelligence tests but it was assumed that this was because
symptoms of the disorder made testing difficult. However, Johnstone et al. (1976)
demonstrated through the use of computerised tomography that chronic
schizophrenics often had abnormally large lateral ventricles, so cognitive deficits
may be expected in conjunction with cerebral pathology. When the cognitive
abilities of chronic schizophrenic patients were examined in more detail, evidence
was found ofwidespread cognitive impairment (Crow and Stevens 1978).
It is now accepted that marked cognitive impairment in schizophrenia is the norm
and also that it may predate illness. The task now is to establish the nature and
degree of impairment. Blanchard and Neale (1994) assert that the lesion-based
approach, (attempting to localise the deficits by using specific neuropsychological
tests purporting to correspond to a specific brain area), may be responsible for the
variability of results between studies of schizophrenia. O'Carroll (2000) suggested
that lack of consensus may reflect the heterogeneity of schizophrenia and the poor
localising ability of standard neuropsychological instruments.
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There is still no real consensus on what the core cognitive dysfunctions in
schizophrenia are. Some studies find changes in memory function generally
(McKenna 1991, Saykin et al. 1994), other studies demonstrate selective executive
function deficits (Weinberger et al. 1986) or widespread neuropsychological
dysfunction (Buchsbaum 1990). Heinrichs and Zakzanis (1998) conducted large-
scale quantitative meta-analysis comparing case-control studies. This meta¬
analysis showed that the largest single impairment was in global verbal memory.
However, several studies with very small sample sizes and therefore limited power
were included in the meta-analysis. Furthermore, as O'Carroll (2000) points out,
there are a large number of impairments, so any specific impairment, such as those
in memory or executive function, exists within a widespread decline in general
cognitive function.
Palmer et al. (1997) subjected a large number of patients and controls to a
comprehensive neuropsychological battery and found that only 27% of the
schizophrenia sufferers were neuropsychologically "normal", thus highlighting that
cognitive impairment in schizophrenia is the norm, but that some patients remain
cognitively intact. This would suggest that the pathophysiology underlying the
cognitive deficits associated with schizophrenia is possibly distinct from that
causing the core clinical symptoms. This is supported by Tsuang (2000) who
asserted that diagnostic categories and psychiatric symptoms may reflect relatively
remote and variable effects of genes predisposing to mental illness. Goldberg et al.
(1993a) found that antipsychotics lead to an improvement in clinical symptoms in
schizophrenics but with no corresponding increase in neuropsychological function.
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2.4.5 Timing of onset of cognitive impairment in schizophrenia
There are problems associated with systematically investigating whether cognitive
impairment predates the onset of schizophrenia. Jones et al. (1994) used data from
the MRC National Survey of Health and Development to select a random sample
of more than 5000 births in England and Wales in 1946. From this sample, 30
cases of schizophrenia developed between the ages of 16 and 43. The entire
sample was tested for non-verbal, verbal and reading abilities at the ages of 8, 11
and 15 and also arithmetic at 11 and 15 and vocabulary at 8 and 11. Analysis of
these tests showed that those children who went on to develop schizophrenia were
significantly impaired on non-verbal and verbal IQ tests from the age of 8 and on
maths skills from 11. This one study detected cognitive abnormalities in childhood
predating the onset of illness. This is suggestive of a possible neurodevelopmental
abnormality. David et al. (1997) described two possible explanations for a link
between cognitive impairment and the onset of schizophrenia. The first may be
that it is directly causal, for example cognitive impairment such as semantic
memory dysfunction producing false beliefs and perceptions where aberrant
connections between 'nodes' in a semantic network could lead to delusions;
another possibility is that of indirect action via any factor causing low IQ, such as
abnormal brain development, which then increases the risk of developing
schizophrenia later.
27
2.4.6 Cognitive decline over time?
Another important issue is whether cognitive ability declines over time. It has long
been assumed that any cognitive impairment in schizophrenia is progressive.
Indeed, Kraeplin's (1896/1987) term "dementia praecox", meaning premature
dementia, implies continuing cognitive decline. It has also been proposed that
acute episodes of schizophrenia are neurotoxic and that the longer the duration of
the initial untreated illness, the poorer the prognosis. There is now, however,
evidence that the cognitive impairment precedes the illness. Russell et al. (1997)
refer to the "myth" of intellectual decline in schizophrenia. They conducted a
follow-up study of patients who had taken an IQ test in childhood and then gone on
to develop schizophrenia, having their IQs tested again nineteen years later. No
differences were found between their childhood and adult IQs. However,
O'Carroll (2000) criticised this study on the grounds that the sample was
unrepresentative because the participants had presented to child psychiatry units
and thus were more intellectually impaired than participants in other studies of
children who later developed schizophrenia. Rund (1998) carried out a
longitudinal review and found that cognitive deficits are relatively stable over time,
a finding that is more consistent with a static encephalopathy rather than
neurodegeneration. However, most clinicians are able to identity patients whose
intellectual functioning declines over the course of their illness. This is suggestive
of a possible subgroup of patients who suffer from a more malignant form of the
disorder that leads to a poorer cognitive outcome.
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2.4.7 Information processing
Another issue of note in evaluating neuropsychological impairment in
schizophrenia is how deficiencies relate to clinical signs and symptoms. Most
researchers agree on the heterogeneity of schizophrenia and it may be the case that
there is no consistent neuropsychological "signature". The syndromes and
symptoms may more closely relate to disordered patterns of information
processing. Information processing or cognitive processes are hypothetical
computational processes which underlie all our behaviour and mental experience
and occur mostly outwith our conscious awareness. Cognitive neuropsychology
attempts to explain the signs and symptoms of mental disorders in terms of
cognitive processes, the theory being that understanding what the specific
impairments are will then lead to an attempt to localise them within the brain
which in turn will inform our grasp of the aetiology. Liddle and Morris (1991)
conducted an important study using an extensive neuropsychological battery of
assessments that were purported to be sensitive to frontal lobe function. They
found that symptoms clustered into three syndromes; a) psychomotor poverty,
associated with slowness in mental activity; b) disorganisation, possibly associated
with a specific difficulty in suppressing irrelevant verbal responses and c) reality
distortion. This is a very interesting approach as it attempts to integrate
neuropsychology with the clinical features of schizophrenia and pursuing this
approach may result in an attempt to explain specific symptoms in terms of
information processing difficulties. Following this line of reasoning, McKenna
(1991) proposed that delusions arise as a consequence of a dysfunctional semantic
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memory. This theory feels intuitively correct, as delusions must represent false
knowledge. However, as yet, no convincing causal relationships have been found.
Frith (1992) has proposed an, as yet purely theoretical, model that attempts to
relate specific signs and symptoms to particular information processing
abnormalities. For example, the inability to monitor the beliefs and intentions of
others leads to delusions of reference, paranoia and third person hallucinations. As
there is no firm evidence as yet to support these theories, this review will
concentrate on empirical findings.
2.4.8 Classical neuropsychology and cognitive processes
Classical neuropsychology attempts to identify sites of brain damage through tests
that are allegedly specific to that site. This means that someone with a lesion in a
particular area should be impaired when tested with an instrument that is supposed
to be specific to that area, whereas a person with a lesion in another area should
perform satisfactorily. However, very few, if any, tests are that specific. Any
neuropsychological instrument involves perception, either auditory or visual,
attentional and central executive processes for allocating cognitive resources, some
working memory (for remembering instructions) and motor control for generating
responses, regardless of what site of interest the instrument purports to test.
Attempts have been made to extend this method to the investigation of
schizophrenia, the results of which have been to implicate almost every brain
region as being crucially involved (see O'Carroll 2000). Frith (1992) asserts that
the problem with these studies is that they used large groups of patients with
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different signs and symptoms at the time of testing. As his theory attempts to link
different signs and symptoms with different cognitive deficits, he claims that the
mean performance of a heterogeneous group of schizophrenia sufferers results in a
very misleading picture. This is a persuasive argument, but needs supporting
evidence.
One flaw in the classical neuropsychological approach is that mere associations
can lead to false positive results. As mentioned above, any psychological test
involves many cognitive processes, only some of which are relevant to localisation.
These may be termed 'specific' and 'non-specific'. If impairment were restricted
to a very small range of tests, it would imply that specific processes are impaired.
This is because non-specific processes will be shared by many tests. Also, if
performance is adequate on most tests, it is likely that non-specific processes
underlying performance are intact. Conversely, if there were wide-ranging
impairment (as is the case with many schizophrenic patients) it would suggest that
there is a deficit, which affects non-specific processes.
2.4.9 Schizophrenia and medication
Much experimental work has been done in schizophrenia but there has been very
little agreement as to the significance of the results and replications of studies have
often produced conflicting results. Some of the problems associated with studying
schizophrenia may arise simply as a result of disease management. Drug treatment
may be a problem as the vast majority of schizophrenic patients are medicated,
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often quite heavily. In investigating schizophrenia it is therefore necessary to
consider whether the drug treatment itselfmay be a contributing factor to cognitive
impairment. Many patients are given a cocktail of drugs in addition to standard
neuroleptics, some ofwhich can produce memory impairment. It would, however,
be difficult to argue that all such cognitive impairments are caused by medication.
For example, most of Kraepelin's patients never received drug treatment but he
asserted that they suffered from a form of dementia. There are, however, problems
involved in trying to surmount the problems of drug treatment. If patients were left
drug-free during the acute stage of the illness, they would usually be unable to
comply with testing. On the other hand, if a clinician were happy to leave a patient
unmedicated and they were happy to undertake psychological testing, they may be
unrepresentative of the sample. Therefore, it is important to control for medication
effects when assessing cognitions.
2.4.10 Schizophrenia and clinical state
There has been some debate in the literature over the years as to whether the
cognitive impairment in schizophrenia is 'real' or merely a consequence of
psychiatric symptoms and lack of motivation. Goldberg et al. (1993a) examined
the relationship between psychotic symptoms and cognition in a group of patients
with schizophrenia treated with neuroleptics over a fifteen-month period. The
authors observed an improvement in psychotic symptomatology as assessed by the
Brief Psychiatric Rating Scale (BPRS) but cognitive function remained impaired.
In a further study, Goldberg et al. (1993b) contrasted the performance on a battery
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of neuropsychological tests of groups of patients with different psychiatric
diagnoses. As no normal control group was included, it is difficult to draw
conclusions on the degree of impairment, however the group found that
symptomatology had a larger impact on test performance in patients with affective
disorder than in patients with schizophrenia. These findings suggest that certain
neuropsychological impairments are relatively independent of psychotic
symptoms, especially in schizophrenia, and that they are likely to be central and
enduring features of the disease process and observable in stable patients.
Furthermore, studies of children at high risk of developing schizophrenia have
demonstrated that such impairments are often evident before the onset of clinical
illness (Wolf and Cornblatt 1996).
As mentioned above, there is a large body of research that confirms that patients
suffering from schizophrenia perform more poorly than normal controls on a wide
variety of cognitive tasks. The literature also suggests that these deficits emerge at
(or before) the onset of diagnosable schizophrenic symptoms and remain fairly
stable throughout the course of the disorder (Heaton and Drexler 1987, Hyde et al.
1994). Controversy again arises as to whether there is a 'generalised' deficit,
which is reflective of cognitive inefficiency, imprecision and psychomotor
slowing, or whether there are specific deficits, which seem differentially severe
and central to the disease process. Current neuropsychological methodology has as
yet failed to find a specific profile of deficits from standardised measurement tools
for any psychiatric disorder (Randolph et al 1993). However, four areas of
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cognitive impairment have been consistently implicated in schizophrenia studies,
these being attention, executive function, memory and language.
2.4.11 Attention in schizophrenia
Gourovitch and Goldberg (1996) state that attentional dysfunction is characteristic
of clinical descriptions of schizophrenia as well as being prominent in patients'
own accounts of their experiences. Reaction time experiments have shown that
schizophrenia sufferers have difficulties relating to the speed at which they can
allocate attention to relevant cognitive activities due to their limited processing
resources. In their review, they describe abnormalities throughout the various
components of attention including simple vigilance, the ability to benefit from
regular or preparatory warning intervals, serial scanning and the ability to sustain
attention over time. This therefore suggests that attention is an important area of
deficit. Like so many processes impaired in schizophrenia, Mesulam (1985) has
suggested that neural structures implicated in the control of attention are widely
distributed rather than focal. However, there is a considerable overlap between
attention and other cognitive functions, as most if not all neuropsychological tests
require some degree of attentional effort.
2.4.12 Executive function
Kraepelin (1921) suggested that dysfunction of the frontal cortex and 'executive
functions' may be responsible for the loss of integrative function in schizophrenia.
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Such deficits can have a substantial impact on everyday functioning, but as Luria
(1980) observed, they can be difficult to determine using standard psychometric
techniques. Shallice (1982) has argued that the frontal lobes play a crucial role in
planning, organising and controlling action and more recently suggests that frontal
lobe dysfunction produces deficits in the Supervisory Attentional System (SAS).
The SAS derives from the Norman and Shallice (1986) model of control of action,
a broad and quite general model. This model assumes that ongoing actions can be
controlled in two ways. The first occurs with well-learned skills, when prior
learning allows the activity to proceed relatively automatically. When two
activities come into conflict, it may become necessary to give one priority. In the
model "contention scheduling" is a process whereby simple rules as to relative
importance are built-in and are operated automatically. The SAS is hypothesised
to have access to a representation of the environment and of the individual's
intentions and cognitive capacities. It is held to operate not by directly controlling
behaviour but by modulating the lower level contention scheduling system by
activating or inhibiting particular schemata. It would be involved in willed actions
and in situations where the routine selection of actions is unsatisfactory, such as
novel situations, decision-making or overcoming temptation. Executive functions
can involve problem solving, set shifting and response to feedback. The Wisconsin
Card Sorting Test (WCST) has been widely used in schizophrenia to investigate
executive function and it has been shown that schizophrenia sufferers have
difficulty attaining concepts and may perseverate on an incorrect response even in
the face of feedback to the contrary (Stuss et al. 1983). The patients are able to
perform the task if they are provided with a structure, but if this is removed they
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tend to return to their previous poor level of performance. Shallice (1988) explains
perseverative errors or difficulty to initiate activity by assuming that there is an
impairment in the functioning of the SAS, so that when a strategy has been adopted
it will continue to run because the capacity to interrupt and change ongoing activity
has been lost. If there is no well-established current activity the system will remain
inert in the absence of the SAS, or tend to be stimulated by environmental stimuli,
giving rise to distractibility. Studies have also shown that schizophrenics have
difficulties with the formation of concepts and hypotheses. Furthermore, patients
tend to exhibit poorer performance than control groups on tasks that measure
guided lexical search such as word fluency (Kolb and Wishaw 1983, Goldberg et
al. 1988). Again referring to Norman and Shallice's model, the fluency task is
presumably difficult for the patient as there is no standard overlearned program for
generating responses. Therefore, the individual must set up and run their own
retrieval strategies whilst also monitoring that the items fit the correct category and
are not repetitions. However, Baddeley (1990) asserts that category generation is
within the capabilities of densely amnesic patients, suggesting that the principle
problem is not with memory in general but with controlling retrieval strategies.
Consistent deficits on executive function tasks combined with behavioural deficits
in schizophrenia such as poor planning, impaired social judgement and insight and
lack of initiative provided the impetus for describing a frontal lobe dysfunction in
schizophrenia.
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2.4.13 Executive function and reactive flexibility
Liddle and Morris (1991) investigated left frontal function in schizophrenia using a
number of tests including the Wisconsin Card Sort Test (WCST) and found that on
the whole, performance was impaired. These impairments were correlated with the
severity of psychomotor poverty and disorganisation, but not with the severity of
reality distortion. Weickert et al. (2000) found subtle deficits on the WCST
relative to controls in patients who displayed otherwise intact intellect, suggesting
that impaired performance is not simply a factor of impaired general cognitive
ability.
Much of the research conducted into executive function in schizophrenia has used
the WCST (Corcoran and Frith 1993). Weinberger and colleagues have
consistently reported deficits in perfusion in the dorso-lateral prefrontal cortex
(DLPFC) in schizophrenic patients when performing this task (Berman et al. 1986,
Weinberger et al. 1988, Weinberger et al. 1986), leading the group to suggest that
the DLPFC has a major role in the pathophysiology of schizophrenia. Other
researchers, however, have suggested that either the medial frontal areas or the left
inferior temporal region rather than the DLPFC are involved in failure to perform
the task (Drewe 1974, Sagawa et al. 1990). As Crowe (1998) points out, these
conflicting results may be explained by suggesting that the schizophrenic patient
places too much reliance on the frontal lobes to carry out this task. Flowever, as
Miller (1983) has commented, poor performance on cognitive tests can be caused
by a number of factors. This may be particularly true in patient groups where
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performance can be affected by medication, compliance and motivation.
Summerfeldt et al. (1991) reported that financial reward could improve
performance to some extent in schizophrenia, suggesting that poor performance is
a consequence of poor motivation. However, Shallice (1988) claims that
motivation is not really plausible as a reason for poor performance as performance
is often comparable to control data in other more complex tasks, such as the WAIS.
It has been claimed that poor performance on tasks such as the WCST occur
because of a breakdown of executive function meaning that the patient is unable to
'abstract', to grasp similarities or essential features. This often results in
persistence of response and failure to shift set. The patient has difficulty dealing
with information from the environment to discover rules, attain concepts and
change behaviour when required to do so (Faglioni 1999).
2.4.14 Executive function and spontaneous flexibility
Another task widely used in studies of schizophrenia to assess executive function is
verbal fluency. Kelly et al. (2000), in a study of cognitive dysfunction in a
community-based population of patients with schizophrenia, found that 49% of all
patients with schizophrenia in an area of southwest Scotland demonstrated frontal
dysfunction as measured by verbal fluency. Vinogradov et al. (2002), in
examining predictors of verbal fluency performance, concluded that the restricted
verbal output of schizophrenic patients was related to both impaired lexical
retrieval and to variation in semantic memory organisation, which partly reflects
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general intelligence. Deficits in verbal fluency tasks often reflect poor spontaneous
flexibility in that the task requires the spontaneous production of a solution or
strategy. The letter condition of the verbal fluency task is considered to be hard
because one must explore the content of semantic memory just by initial letter and
ignore the actual meaning, rather than using semantic cues which are how things
are normally retrieved. Poor performance in the category condition may reflect a
disorganised semantic store, or degradation of that store.
Byrne et al. (1999) assessed neuropsychological function in young people at high
genetic risk of developing schizophrenia and found no significant differences
between the high-risk group and normal controls in terms of verbal fluency.
However, as the high-risk group was a young, well population tested on a wide-
ranging neuropsychological battery, one would not necessarily expect significant
differences between groups on all tasks. However, after controlling for differences
in IQ, group differences remained for aspects of another test of executive function,
the Hayling Sentence Completion Test. This test measures basic initiation speed
and response suppression. High-risk subjects made significantly more errors and
took longer to complete the task. This type of task reflects the inhibitory and
regulatory activity of executive function (and putatively the frontal lobes). This is
critical in allowing freedom of choice with regard to what information to accept
and operations to carry out. The inability to plan actions and anticipate
consequences is found with a tendency to produce the most obvious response even
if it is inappropriate (Faglioni 1999).
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The literature suggests that many of the cognitive deficits observed in
schizophrenia are found in patients with negative rather than positive symptoms.
Pantellis and Nelson (1994) claim that these are suggestive of a subcortical
dementing process. The deficits observed include poor attention, concentration,
memory, planning and activation. Crowe (1998) asserts that the pattern of
executive dysfunction in schizophrenia is more in keeping with erosion of levels of
drive and activation rather than the disinhibited basal forebrain style of executive
disorder, and therefore consistent with a compromised dorso-lateral prefrontal
cortex and connections to the brain stem, producing a marked avolitional state and
overall diminution of drive and direction.
2.4.15 Memory
As Baddeley (1990) has pointed out, 'memory' as such is not a homogeneous and
unified function but has many different aspects, each of which is characterised by a
specific profile and involving different neurobiological systems. A more
fundamental distinction is that between long-term memory (LTM) and short-term
memory (STM). Long-term memory seems to have limitless capacity and involves
handling information from over thirty seconds to many years. Short-term memory
seems to have only a very limited capacity for only a few seconds. Long-term
memory can be further divided into episodic memory (for personal experience),
semantic memory (for general knowledge) and procedural memory (for skills).
These different aspects can be affected to different extents in different illnesses.
Chen and McKenna (1996) assert that from a clinical viewpoint, the relationship
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between memory dysfunction and the emergence of psychiatric symptoms is an
important issue. Memory is an important component in many everyday cognitive
processes that underlie conscious experience. Chen and McKenna claim that it is
possible that memory problems could lead to distortions and aberrations in
ordinary experiences and that some of these may be related to the symptoms and
disability observed in schizophrenia although this needs further investigation.
Memory dysfunction in schizophrenia was not considered an important feature of
the disorder until fairly recently. Both Kraepelin (1921) and Bleuler (1913/1950)
considered memory in schizophrenia to be largely unaffected. In his review,
Cutting (1990) held that memory impairment was not observed except in severely
disabled chronic patients with widespread cognitive dysfunction. However, recent
systematic studies, which have taken account of factors such as premorbid IQ and
current overall cognitive performance, have reported a disproportionate degree of
memory impairment in a number of patients with both chronic and acute
schizophrenia.
Memory dysfunction is one of the most reliable findings in cognitive studies of
schizophrenia (Levin et al 1989). Deficits have been reported in a variety of
paradigms implicating all stages of memory function from initial encoding to
consolidation through to retrieval and recognition (Saykin et al. 1991, Calev el al.
1983,1987). There has been some controversy as to whether the memory deficits
observed in schizophrenia are primary or whether they are secondary to other
deficits such as in attention or executive function. However, various studies have
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demonstrated consistent memory deficits. It has been shown that generally, the
learning rate begins and ends more slowly in schizophrenia sufferers relative to
controls (Goldberg et al. 1989). Kolb and Wishaw (1983) further demonstrated
that schizophrenics' ability to recall stories and abstract designs is impaired
compared to normal control groups. Gold et al. (1992a) found that schizophrenic
patients' exhibited poorer performance on the Weschler Memory Scale-Revised
(WMS-R) than on the Weschler Adult Intelligence Scale-Revised (WAIS-R).
Thirty percent of the patients investigated in the study had a general memory index
(both visual and verbal) fifteen or more points below their full-scale IQ. It is not
however clear whether specific aspects of the memory system are differentially
affected. McKenna et al. (1990) studied 60 patients with schizophrenia with
varying degrees of illness severity. The authors found a pattern of memory
performance, which was similar to that of classical amnesia, in that short-term
memory remained intact but long-term memory and recognition were impaired.
Another study conducted by Gold et al. (1992b) compared groups of
schizophrenics and normal controls. A wide variety of memory deficits were
demonstrated by the schizophrenic group, including recall ability, failure to utilise
semantic cues aiding recall, recognition, attenuated sensitivity to frequency
information and a tendency to make prior list and non-list intrusions. These
impairments were shown in both effortful and more automatic memory functions,
so the authors concluded that these results supported the notion of dysfunction of
encoding of semantic information, frequency estimation and temporal order cues.
The above evidence supports a hypothesised memory disorder involving functional
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compromise of neural systems involved in the acquisition of new information
associated with frontal and temporal lobes.
2.4.16 Short term memory in schizophrenia
Baddeley (1986) has extended the concept of a short-term memory store into a
working memory system involving at least two "slave" subsystems (verbal
phonological and visuospatial) and a "central executive system". Studies of
working memory in schizophrenia have tended to focus on digit span. Gruzelier et
al. (1988) investigated digit span in groups of schizophrenics, affective disorder
patients and controls and found that compared to controls, patient groups were
found to have slightly shorter spans for both digits and Corsi blocks. Tamlyn et al.
(1992) found that of groups of both acute and chronic schizophrenic patients, 86%
had digit spans of at least five, the remainder having spans of four. Duffy and
O'Carroll (1994) demonstrated that patients with schizophrenia and Korsakoff s
both had forward digit spans within normal limits. Goldberg et al. (1993c)
investigated digit span in monozygotic twin pairs discordant for schizophrenia.
Forward digit span was found to be equal in affected and unaffected twins, whereas
backward digit span showed a non-significant trend towards poorer performance in
affected co-twins. It seems from these verbal working memory studies that most
schizophrenics have a forward digit span within the normal range. There are
however some suggestions that mean digit span may be marginally impaired. The
difference may be more pronounced in backward digit span, although this is often
not reported. Tamlyn et al. (1992) have suggested that if there is a subtle working
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memory deficit, it does not appear to be correlated with other memory deficits.
They found that the schizophrenics involved in their study had specific and
substantial degree of overall impairment in long term memory rather than short
term memory, with relatively preserved Short Term Memory. Chen and McKenna
(1996) also point out that this preservation is also shown by preservation of the
recency effect in recall.
2.4.17 Long term memory in schizophrenia - retrograde studies
Investigations into long-term memory in schizophrenia can be fractionated into the
memory subsystems outlined above. Retrograde studies of episodic memory assess
memory for remote events acquired over long periods and determine the presence
of a temporal gradient in episodic memory impairment (Butters and Cermak 1986).
However, Chen and McKenna (1996) assert that this approach is vulnerable to
methodological problems. For example, it is difficult with a list of famous events
or personalities to assess whether any failure is due to memory impairment or to a
longstanding lack of awareness. Calev et al. (1987) tested chronic schizophrenics
and normal controls on the Famous Events Questionnaire and found that remote
episodic memory was impaired in the schizophrenia group and also that there was
no apparent temporal gradient. Tamlyn et al. (1992) with the same group of
schizophrenics mentioned above found that all of them demonstrated poor
performance compared to normal controls on the famous personalities test. There
are very few studies to consider in this area but they do suggest that episodic
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memory is impaired in schizophrenia but unlike classical amnesiac disorder, there
is no clear temporal gradient.
2.4.18 Long term memory in schizophrenia - anterograde studies
Anterograde studies of episodic memory are tasks involving memorising items and
subsequently testing retention of material either by recall or recognition. They
involve a short time span and experimentally controlled presentation of items.
Again, Chen and McKenna (1996) express concerns over possible methodological
problems with tasks requiring the acquisition of new material, such as motivation
and "input" factors such as attention. The objective of such tasks is to produce
memory traces that are distinct from other traces. These traces are better examined
through recognition rather than recall because the latter requires additional
cognitive activity to access the items. Baddeley (1990) claims that similarity
between the items will interfere with recognition but have variable effects on recall
- it may assist access but interfere with discrimination. This underlies the
observation that high frequency words tend to be recalled more easily whereas low
frequency words tend to be recognised more easily. The assessment ofmemory by
recognition is also complicated by the readiness of subjects to guess and answer
when they cannot remember with certainty but have a vague sense of the answer.
Calev et al. (1983), in a study involving groups of chronic and acute schizophrenic
patients, tried to facilitate encoding with the introduction of an orienting task. This
was achieved by getting the participants to sort the stimuli into semantic categories
prior to learning and recall tests. Deficits were found at both the encoding stage in
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the chronic and mild groups and in the post-encoding stage in the chronic group.
Calev (1984) investigated the performance of chronic schizophrenics and normal
controls on recall and recognition tasks matched for difficulty level. He found
deficits in both in the schizophrenic group with recall being differentially more
impaired. This suggests retrieval deficits with problems accessing stored material.
Tamlyn el al. (1992) tested groups of acute and chronic schizophrenic patients on
the Rivermead Behavioural Memory Test and found them to be impaired on most
measures of long-term memory. A further study of five patients who were very
impaired with the Recognition Memory Test found variable impairment for both
word and face recognition. The authors concluded that both recall and recognition
are impaired in schizophrenia. These are, however, tiny numbers from which to
conclude anything. Goldberg et al. (1993c) in a study of discordant monozygotic
twin pairs on paired associate learning found that the affected twins demonstrated
poorer performance than the unaffected twins who were more similar to normal
controls. No differences between the groups were found for delayed recall.
However, the twins with schizophrenia failed to take advantage of semantic
regularities as was observed in the other groups. These studies, although very
small scale, show that there may be at least some evidence for impairment of Long
Term Memory in schizophrenia, but the presence of a learning curve over trials
argues against the notion that schizophrenics are similar to patients with amnesic
syndrome.
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2.4.19 Semantic memory in schizophrenia
Semantic memory refers to memory for facts, ideas and concepts that are not
personal in nature. These are organised conceptually and with little temporal
coding. As Baddeley (1990) states, this system is typically spared in classical
amnesic syndrome. Category specific deficits have been found in some patients
with brain lesions (Warrington and Shallice 1984), which is suggestive of
topographical organisation. Tamlyn et al. (1992) in their study of acute and
chronic schizophrenic patients tested them on the Silly Sentences test. They found
that reaction time was increased in the schizophrenic groups with two thirds of
them outside the normal range. Normal controls rarely make errors on this task,
but 14 out of 60 schizophrenics made three or more mistakes, with five of them
making more than ten errors. The tendency was for the patients to misclassify the
statements as true and when questioned to give irrational reasons for their
responses. McKenna et al. (1994) tested 41 schizophrenic patients ranging from
chronic to mild with the Hodges Semantic Memory Test. This assesses different
aspects of semantic memory including category fluency, naming, sorting and
definition. The patients as a whole demonstrated impaired performance on many
aspects. These studies suggest a specific anomaly in semantic memory function in
schizophrenia. Chen et al. (1994) devised a categorisation task requiring a yes/no
response, for example whether the exemplar 'chair' belongs to the category
'furniture'. The internal category structures appear to be intact in schizophrenia
but items clearly outside the category boundary but related in some attributes - for
example 'aeroplane' and the category 'birds' - seem to be treated as though they
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were on the category boundary. Reaction time analysis shows that normal controls
take longest to respond when an item is on the boundary but for schizophrenics the
longest reaction times are for items outside the boundary but related. This is
suggestive of disorganisation of semantic store.
2.4.20 Verbal versus nonverbal memory in schizophrenia
Some theories have suggested lateralisation in schizophrenia, which has led to the
comparison of verbal and spatial memory. So far, the results have proved
inconclusive. Chen and McKenna (1996) suggest this is due to serious
methodological problems in that studies, which have reported laterality differences,
have not employed verbal and non-verbal tasks, which are matched for difficulty
level.
Deficits in both visual and verbal recall have been reported with some consistency
in the literature, suggestive of disruption in cortical networks (Corcoran and Frith
1993).
Spatial memory tasks have also distinguished between schizophrenia sufferers and
other patient groups (Park and Holtzman 1992). They claim that this suggests a
failure in representational processing independent of modality. Archer et al.
(1992) demonstrated that schizophrenic patients were less accurate than either
depressed patients or healthy controls in recognising familiar faces, naming
emotions shown in photographs or in distinguishing previously seen faces from an
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array of distracters. This suggests a generalised failure of recognition of visual
items.
2.4.21 Specific memory impairment in schizophrenia?
It appears that the pattern of memory impairment in schizophrenia has unique and
specific features, which may eventually be related to the involvement of a specific
set of neural subsystems. It is, however, well recognised that a number of
schizophrenic patients have global cognitive impairment. This gives rise to the
question of whether memory dysfunction in schizophrenia occurs entirely in the
context of global impairment or whether it can be considered as a distinct
psychological deficit. Braff et al. (1991) took an outpatient sample and found that
schizophrenics have a non-specific and heterogeneous pattern of
neuropsychological deficits. However, as Chen and McKenna (1996) point out,
the study did not employ an extensive memory test battery. However, Tamlyn et
al. (1992) found that the distribution of scores in their study suggested that the
memory impairment is disproportionate to any generalised cognitive impairment.
Duffy and O'Carroll (1994) confirmed this.
The specificity and extent of memory deficits in schizophrenia remains an area of
contention (Calev et al. 1991). Aleman et al. (1999) conducted a meta-analytic
review of memory impairment in schizophrenia and found evidence for a
significant memory impairment that was stable, wide-ranging and not substantially
affected by potential moderator variables such as symptom severity or duration of
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illness. The composite effect size for recall performance (both verbal and non¬
verbal) was large, and recognition memory showed less but still significant
impairment. Impairments in encoding and consolidation have been associated with
hippocampal and temporal lobe dysfunction (Squire 1992, Hjiman 1996).
Furthermore, frontal lobe systems, which may also be affected in schizophrenia
have been to be involved in free recall of declarative memory (Wheeler et al. 1995,
Ungerleider 1995).
2.4.22 Memory deficits in different illness stages in schizophrenia
The effect of length and severity of illness upon memory performance has
produced variable results. However, studies have shown that memory impairment
is prevalent in schizophrenia. McKenna et al. (1990) established that, using a test
of 'everyday' memory, the performance of schizophrenic patients was no better
than that of a sample of moderate or severe brain injured patients, and that this was
not restricted to chronic patients, but seen in acute and remitted patients as well.
Byrne et al. (1999) further demonstrated that individuals at high genetic risk for
developing the disorder recalled fewer words than age and sex matched normal
controls on all trials of the Rey Auditory Verbal Learning Test, suggesting that this
is a stable trait deficit, possibly neurodevelopmental in origin. However, these
results could be accounted for by the difference in IQ between the groups.
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Levin et al. (1989) claim that mildly disturbed schizophrenic patients show more
deficits in encoding and organisation of material, whereas severely disturbed
patients show something akin to retrograde amnesia. This, however, is at odds
with the findings of Hoff et a/.'s (1992) study, comparing first-episode
schizophreniform patients and chronic schizophrenic patients in verbal and visual
memory performance. No differences were found between the patient groups
although both performed worse than healthy controls.
2.4.23 Recall versus recognition in schizophrenia
Gold et al. (1992b) theorise that memory deficits in schizophrenia are due to a
disruption in the encoding of material, producing a lack of distinctiveness and
specificity of verbal items. However, Paulsen et al. (1995) found evidence for a
prominent retrieval deficit in schizophrenia, characterised by moderate to severe
impaired total recall across all trials of the California Verbal Learning Test in the
context of only mildly impaired recognition impairment. The schizophrenic
patients in Paulsen et cz/.'s (1995) study further demonstrated a tendency to make
phonologically related false positive errors in recognition, suggestive of superficial
rather than semantic encoding, which is consistent with the Gold et al. (1992b)
study findings.
Wood and Flowers (1990) examined cerebral blood flow in schizophrenia over
repeated trials of a verbal recognition task. Both schizophrenic and bipolar groups
could be distinguished from the unipolar depressed and healthy control groups on
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the narrative prose task. However, they claimed that schizophrenia is "uniquely
associated" with hypofrontal blood flow, failure of the frontal lobe to appropriately
supervise decision processes in memory retrieval and recognition.
The evidence pertaining to memory function in schizophrenia does consistently
report deficits in verbal and visual recall, especially in severely disturbed
schizophrenia sufferers, similar to those found in classical amnesic syndrome,
which suggests bilateral hippocampal involvement as the hippocampal complexes
are involved in the acquisition of new factual knowledge, and specialised for
different types of knowledge in a manner paralleling the usual functional
arrangement of the brain (Tranel and Damasio 1996). In more mildly disturbed
patients, and in patients with bipolar affective disorder, memory deficits are
associated with poor organisation of material, producing disrupted encoding, and
leading to disruption of attentional and organisational functions (Crowe 1998).
2.4.24 Association of memory and executive function
A relationship has been found between memory impairment and executive
function. Some authors have noted that the memory impairment in schizophrenia
appears to affect recall over recognition and have suggested that this may reflect an
executive pattern of impairment (Goldberg et al. 1989). However, as Tamlyn et al.
(1992) have shown, intact recognition is not a universal finding. The frontal lobes
have a role to play in executive function but it is not clear whether frontal lobe
lesioned patients always show a pattern of impaired recall with relatively intact
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recognition. For example, Delbecq-Derousene et al. (1990) report a patient with
frontal lobe syndrome who showed selectively impaired recognition memory and
Hirst (1982) report a disparity between recall and recognition in classical amnesic
syndrome without frontal lobe involvement. Another important question is
whether executive function deficits as reported in schizophrenia are
disproportionate to the overall level of poor intellectual functioning. Conclusions
cannot yet be drawn with any confidence on this issue. Saykin et al. (1991)
employed an extensive battery of tests and found that when scores were compared
across tests, patients were no more impaired on executive function tasks than on
anything else. Indeed learning and memory deficits were significantly more
prominent than any executive dysfunction. However, Shallice et al. (1991)
employed a similarly wide battery and found a more or less consistent pattern of
severe executive impairment. The authors argue that executive dysfunction is the
common denominator of neuropsychological impairment and when it is present in
relative isolation, it could plausibly account for poor performance on some
memory tasks, for example compromised frontal lobe systems have been shown to
be involved in the active retrieval of declarative memories (Ungerleider 1995).
2.4.25 Language in schizophrenia
A further area of cognitive impairment implicated in schizophrenia is that of
language. One component of thought-disordered language is the lack of executive
planning and editing of discourse together with the inability to inhibit inappropriate
associations. Barr et al. (1990) showed that the majority of errors in language
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functioning as exhibited by schizophrenic patients such as perseveration of words
and perseveration of prior semantic and phonemic properties of words are related
to executive dysfunction.
Gourovitch and Goldberg (1996) suggest that errors in schizophrenic speech have
more to do with the inability to inhibit irrelevant or facilitate relevant activated
units of language rather than a breakdown of the semantic system per se.
2.5 Endophenotypes in Schizophrenia
Diagnosis of schizophrenia relies on clinical symptoms reported by the patient.
The picture might change if we had reliable biological markers of risk to assist in
determining who is a "case". Much research has been directed towards the
identification of biological variables that could act as trait markers of risk of
disease. Endophenotypes are heritable traits associated with the expression of an
illness. For example cognitive deficits discussed in Section 2.4 may be considered
as possible endophenotypes for schizophrenia and abnormal neurophysiological,
biochemical, endocrinological and neuroanatomical findings have all been
proposed. Leboyer et al. (1998) state that in order to meet the criteria for a marker
trait, an endophenotype must occur before the onset of illness and must be
heritable. Specific physiological responses such as eye movements and the
auditory P300 event related potential. (Blackwood et al. 1990) are deemed to be
endophenotypes. Roxborough et al. (1993) investigated neuropsychological and
P300 abnormalities in schizophrenic patients and in relatives of schizophrenics and
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found that patients performed less well than controls on neuropsychological tasks
believed to be sensitive to frontal and temporal lobe impairment. Furthermore, the
patients showed prolonged P300 latency. The relatives of schizophrenic patients
fell into two groups. Those with abnormal P300 showed similar deficits to the
schizophrenic patients, but those with normal P300 performed at the level of the
normal comparison group. Shajahan et al. (1997), in a relatively small-scale study,
found lower amplitude and longer latency of P300 in schizophrenics when
compared with age- and gender-matched normal controls. Correlations were also
found between P300 amplitude and latency and neuropsychological performance in
the patient group. Blackwood et al. (1999) found that, in patients with
schizophrenia and their relatives, altered cerebral perfusion as measured by single
photon emission computed tomography (SPECT) was correlated with verbal
memory and P300 abnormalities.
Findings from the Edinburgh High Risk Study confirm that neuropsychological
impairment may be a risk indicator. In a recent paper, Byrne et al. (1999) showed
that high-risk subjects performed more poorly than controls on test of intellectual
function and on aspects of executive function and memory. However, to be useful
as an aid to diagnosis, a disease endophenotype must fulfil the following criteria:
1. Be related to disease at the population level.
2. Segregate with illness in families.
3. Clearly differentiate "affected" from "unaffected" individuals. In
practice that requires a mean level in "affecteds" more than three
standard deviations from the control mean.
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To date, no biological variable has been shown to fit these criteria
schizophrenia.
3.0 UNIPOLAR AFFECTIVE DISORDER
3.1 General Description
The aetiology of affective disorders is not fully understood and like schizophrenia,
definitions are based on the presence of specific signs and symptoms. The
fundamental feature of an affective disorder is a severe and prolonged disturbance
of mood which may be depression and anxiety if a patient is diagnosed with a
depressive illness, of elation and excitement if a patient is diagnosed as being in a
manic or hypomanic state. Unipolar depression will be described first.
Kraepelin's original concept of manic-depressive illness was a catch-all for all
illnesses with manic or depressive symptoms or a mixture of the two regardless of
duration or specific symptomatology. It was not until Angst (1966, cited in
Nurnberger and Berrettini 1998) and Perris (1966) drew attention to the differences
between patients suffering from periods of mania and periods of depression and
those patients who only suffered from depressive episodes that the original concept
was seriously challenged.
Evidence from family studies suggests that unipolar and bipolar disorders should
be considered as two disorders rather than a unitary one. Perris (1966) found an
increased risk of bipolar illness and unipolar depression in first-degree relatives of
bipolar patients, and a high risk of unipolar illness and no increase in bipolar
illness in the relatives of unipolar probands. Angst (1966) found that relatives of
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bipolar patients had a high risk of both unipolar and bipolar disorder, while the
relatives of unipolar probands had a high risk only of unipolar disorder.
In DSM-IV the major affective disorders are sub classified as bipolar and unipolar
disorders. The essential feature of a bipolar illness is the presence of one or more
episodes of mania or hypomania usually, but not exclusively, occurring with a
history of major depressive episodes. The diagnosis of unipolar depressive
disorder requires one or more episodes of depression with no history of either
mania or hypomania.
The DSM-IV (APA, 1994) diagnostic criteria state that for a diagnosis of Major
Depressive Disorder the patient must have:
At least one of the following three abnormal moods which significantly interfered
with the person's life:
Abnormal depressed mood most of the day, nearly every day, for at least two
weeks.
Abnormal loss of all interest and pleasure most of the day, nearly every day, for at
least two weeks.




Abnormal loss of all interest and pleasure.
Appetite or weight disturbance, either:
Abnormal weight loss (when not dieting) or decrease in appetite or
Abnormal weight gain or increase in appetite.
Sleep disturbance, either abnormal insomnia or abnormal hypersomnia.
Activity disturbance, either abnormal agitation or abnormal slowing (observable by
others).
Abnormal fatigue or loss of energy.
Abnormal self-reproach or inappropriate guilt.
Abnormal poor concentration or indecisiveness.
Abnormal morbid thoughts of death (not just fear of dying) or suicide.
The following are exclusion criteria:
The symptoms are not due to schizophrenia.
There has never been a manic episode, a mixed episode or a hypomanic episode.
The symptoms are not due to physical illness, alcohol, medication or street drugs.
The symptoms are not due to normal bereavement.
Appetite disturbance can be manifested as either increased or decreased desire for
food which leads in turn to a corresponding loss or gain in weight. Similarly, sleep
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disturbance can take the form of either insomnia or hypersomnia. Lack of sleep
may result from being unable to fall asleep on first going to bed, restlessness and
waking during the night and waking very early in the morning and being unable to
fall back to sleep. Alternatively the patient may find that he is sleeping far more
than usual and spending most of the day in bed. The depressive patient may
experience psychomotor agitation, being unable to sit still, or psychomotor
retardation in which he feels very much 'slowed down'. The patient often
expresses feelings ofworthlessness and guilt and also slowness of thinking.
Other characteristic signs of depression are tearfulness, anxiety, irritability,
obsessive ruminations, excessive concern with physical health, panic attacks and
phobias. If delusions and hallucinations are experienced they tend to be mood-
congruent. Commonly, delusions take the form being punished or persecuted due
to some moral transgression or personal inadequacy. The patient may present with
nihilistic delusions of the world or personal destruction, somatic delusions of
serious illness or delusions of poverty. Hallucinations, if they occur, are usually
transient, involving accusatory or condemnatory voices.
The onset of a major depressive episode can be variable. Symptoms tend to
develop over a period of days or weeks, although in some cases the onset can be
relatively sudden, for example as a reaction to stress. In a number of cases there
are prodromal symptoms such as generalised anxiety, panic attacks phobias or mild
depressive symptoms (Goodwin 1998).
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The duration of a major depressive episode is also very variable. If left untreated,
the episode will generally resolve itself in six months or longer. Usually, there is a
complete remission of symptoms and general functioning returns to the premorbid
level. Some patients experience episodes of depression separated by several years
of normal functioning. Other patients suffer clusters of episodes; others still have
increasingly frequent episodes as they grow older (Kendell 1987).
3.2 Epidemiological Findings
Studies of the prevalence of Major Depressive Disorder in the USA and Europe
have reported values of between 4.9% to 8.7% for females and 2.3% to 4.4% for
males (Weissman et al. 1996)
In unipolar disorder the mean age at onset shows little variation, being between
24.8 and 34.8 years (Weissman et al. 1996) and the rates of major depression are
usually higher for women than men (Angold and Worthman 1993).
3.3 Cognitive Impairment in unipolar depression
3.3.1 Memory
Until relatively recently it was believed that even severe depression was associated
with only minor impairment in cognitive function. However, more recent research
has clearly established that memory functioning appears to be impaired in major
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depression and this is not simply due to reduction in motivation (Richards and Ruff
1989). Ilsley et al. (1995) compared patients suffering from major depression with
controls marched for age, sex and IQ on a battery of tests aimed at fractionating
memory dysfunction in depression. Patients were unimpaired relative to controls
on measures of short-term memory, recognition, semantic memory and implicit
memory. No correlation was found between depression severity and level of
memory impairment. It was found, however, that the depressed patients
demonstrated deficits in psychomotor speed and in immediate and delayed free
recall. This would suggest that material is satisfactorily encoded but that the
patients are particularly impaired with regard to search and retrieval processes.
Austin et al. (2001) carried out a review of the literature examining cognitive
deficits in depression and their brain correlates. Cognitive deficits are often
viewed as epiphenomena of the disorder. The review concluded that depression is
associated with a number of deficits in episodic memory and learning and appears
to involve both explicit verbal and visual memory. Implicit memory tasks appear
to be spared. Sheline et al. (1996) found reductions in volume of the hippocampus
in patients with major depression and this ties in with these findings as temporal
lobe lesions typically disrupt episodic memory.
3.3.2 Executive function
Studies investigating executive function in depression have produced conflicting
results but in general significant impairment was found in patients with severe
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depression. The review suggests that executive deficits may be selective for set-
shifting tasks. Several studies suggest that these impairments occur independently
of age, depression severity and subtype, task difficulty, motivation and response
bias. A few studies suggest that cognitive deficits may persist upon recovery and
that these findings are reported in all age groups, although more frequently in older
patients. The presence of neuropsychological deficits is important evidence that
enduring brain abnormalities are implicated in the aetiology of depression because
if cognitive impairment were simply secondary to the severity of depressed mood,
it would be expected to fully recover with the remission of the acute episode.
Purcell et al. (1997) investigated cognitive function in younger out-patients with
moderate depression, and found no impairment in working memory, but impaired
motor speed and attentional set shifting, with around half the depression group
failing to complete the task. Impairment was associated with the number of
admissions, suggesting that patients with greater illness severity are more impaired
on set shifting tasks.
Channon and Green (1999) further investigated executive function in depression,
working on the notion that depressed patients fail to generate or implement
adequate performance strategies. This followed on from an earlier study
(Channon, 1996) investigating the performance of dysphoric undergraduates on the
WSCT, the findings of which were consistent with models of depression which
conceptualise it in terms of impaired executive functioning on effortful tasks with
intact automatic processing. Unipolar patients were compared with matched
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healthy controls on tasks sensitive to executive function and were found to be
impaired relative to controls and to use appropriate strategies spontaneously less
often, although their strategies were similar. The findings of this study are
consistent with cognitive models predicting impairment in controlled processes in
depression resulting from reduced or diverted attentional processing resources.
As there is evidence for reduced prefrontal cortical blood flow and metabolism in
both depression and schizophrenia, Merriam et al (1999) conducted a study to
directly compare these two groups along with a healthy comparison group on the
Wisconsin Card Sort Test as it is sensitive to such dysfunctions. The findings
showed that depressed patients were significantly impaired on the task relative to
the healthy controls, although unsurprisingly these deficits were less severe than
those exhibited by the schizophrenic patients. The authors suggest that the
difference in performance deficits between the patient groups may be due to the
greater severity of illness in the schizophrenics. However, it may rather be due to
disorder-specific effects on prefrontal cortex function. The authors do conclude
that as there was an association between cognitive impairment and depressive
symptoms, these findings may be state-dependent.
3.3.3 Cognitive performance and clinical state
Much of the literature relating to cognitive impairments in depression suggests that
these abnormalities are more pronounced in elderly patients or midlife patients
with psychotic features. Little work has been conducted in younger patients. This
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is an important area of study because early onset depression may be a distinct
subgroup of the disorder. Grant et al. (2001) conducted a large scale study with
the express intention of addressing this issue, including 123 nonbipolar,
nonchronic, unmedicated patients with major depressive disorder and an age- and
gender-matched healthy comparison group. The authors were struck by the
absence of significant cognitive impairment in this group of depressed patients.
There were mild impairments in executive function as measured by the Wisconsin
Card Sort Test but attention, memory and motor functioning appeared to be intact.
Sweeney et al. (2000) directly compared the performances of bipolar and unipolar
patients on the Cambridge Neuropsychological Test Automated Battery
(CANTAB). Manic and mixed affective state bipolar patients demonstrated
deficits in episodic and working memory, spatial attention and problem solving.
However, depressed bipolar and nonbipolar patients demonstrated only
impairments in episodic memory. These findings suggest that neuropsychological
deficits are significantly more pronounced in mixed/manic phases than during the
depressed phase of bipolar disorder, and indeed that the pattern of
neuropsychological deficits is similar in bipolar and nonbipolar depression. The
authors suggest that such deficits may be related primarily to the state of illness at
the time of testing rather than persistent stable cognitive deficits. This, however,
warrants further investigation.
Thus depression results in a disruption of orderly information processing,
characterised by relatively poor performance on memory and higher level problem
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solving tasks. It may be that these deficits are more indicative of a loss of effortful
processing rather than intrinsic problems with information processing per se and it
may be that these deficits are state rather than trait dependent.
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4.0 BIPOLAR AFFECTIVE DISORDER
4.1 General Description
Similar to schizophrenia and unipolar affective disorder, the aetiology of bipolar
disorder is not entirely clear, and diagnosis is made on the basis of signs and
symptoms.
Originally Kraepelin (1921) combined unipolar and bipolar illnesses within his
category of manic-depressive psychosis. It was not until Leonhard (1957)
separated unipolar and bipolar affective disorders that they came to be investigated
as discrete illnesses for research purposes. However, the distinction between the
two is not always so clear-cut. It is well established that between ten and twenty
percent of patients whose first episodes of illness are all depressive in nature and
are therefore initially classified as suffering from a unipolar depressive illness will
go on to develop manic episodes and consequently be reclassified as bipolar
(Kendell 1987). Akiskal (1983) states that there are a number of features which a
unipolar patient who is subsequently diagnosed as bipolar tends to exhibit. These
include early onset (before the age of 25), especially acute onset, psychotic
depression, postnatal depression, a hypersomnic retarded clinical picture,
hypomania triggered by antidepressant drugs or ECT and a family history of
bipolar disorder.
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Leonhard's (1957) distinction between unipolar and bipolar disorders has been
supported by a number of findings. These include investigations of familial
distribution, natural history and response to treatment. The rate of illness found in
first-degree relatives varies to a significant extent between unipolar and bipolar
probands. Perris (1966, cited in Nurnberger and Berrettini 1998) found that the
risk of affective illness is increased in relatives of bipolar patients. In a study of
138 bipolars and 139 unipolars, bipolar family history was found in 16% of the
cases and a family history of unipolar disorder in 0.8% of the bipolar probands. In
the unipolar probands, a family history of bipolar disorder occurred in 0.5% of
cases and family history of unipolar disorder in 10.6% of cases. Twin studies have
revealed increased concordance between bipolar monozygotic twins than between
unipolar monozygotic twins, suggesting a greater genetic contribution.
Bipolar illnesses are usually classified according to the predominant mood of the
current episode. Thus the patient may be described as being in a manic or
depressed or separately a mixed state if elation and depression are exhibited at the
same time.
The DSM-IV (APA, 1994) diagnostic criteria for bipolar I disorder are as follows:
For a manic episode:
A distinct period of abnormally and persistently elevated, expansive or irritable
mood, lasting at least one week (or any duration if hospitalisation is necessary).
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During the period ofmood disturbance, three (or more) of the following symptoms
have persisted (four if the mood is only irritable) and have been present to a
significant degree:
Inflated self-esteem or grandiosity.
Decreased need for sleep (e.g. feels rested after only three hours of sleep).
More talkative than usual or pressure to keep talking.
Insomnia or hypersomnia nearly every day.
Psychomotor agitation or retardation nearly every day (observable by others, not
merely subjective feelings of restlessness or being slowed down).
Flight of ideas or subjective experience that thoughts are racing.
Distractibility (i.e. attention too easily drawn to unimportant or irrelevant external
stimuli).
Increase in goal-directed activity (either socially, at work or school, or sexually) or
psychomotor agitation.
Excessive involvement in pleasurable activities that have a high potential for
painful consequences (e.g. engaging in unrestrained buying sprees, sexual
indiscretions or foolish business investments).
The symptoms do not meet criteria for a mixed episode.
The mood disturbance is sufficiently severe to cause marked impairment in
occupational functioning or in usual social activities or relationships with others, or
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to necessitate hospitalisation to prevent harm to self or others, or there are
psychotic features.
The symptoms are not due to the direct physiological effects of a substance (drug
of abuse or medication) or a general medical condition.
For a depressed episode:
The patient must fulfil the same criteria given for unipolar affective disorder.
Associated symptoms may include inflated self-esteem, grandiosity and decreased
need for sleep, pressure of speech, flight of ideas, distractibility, excessive and
impracticable planning, psychomotor agitation and unwarranted involvement in
activities the desirability or feasibility of which the sufferer may not examine.
Inflated self-esteem can range from uncritical self-confidence to marked
grandiosity which is often delusional. The patient may feel that he is very
important and have special powers, plans and abilities. The patient feels less need
for sleep but still feels full of energy. If the sleep disturbance is especially severe
the patient may go for several days without feeling the need for sleep or feeling
that he is too busy to waste time in sleeping. Manic patients often talk more than is
usual or feel the pressure to keep on talking. Manic speech is characterised by
increased volume, rapidity and difficulty of interpretation. It may be full of jokes,
puns, plays on words and irrelevancies. The patient may experience flight of ideas
which is exhibited in a flow of accelerated speech with abrupt changes from topic
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to topic. These rapid changes in topic are typically based on understandable
associations, distracting stimuli or plays on words. In very severe cases speech
may be disorganised and incoherent.
A manic patient can be distractible in that he may have difficulty concentrating on
events round about him because his attention switches to unimportant items. This
is apparent through rapid changes in speech or activity due to responding to
irrelevant external stimuli. The patient can also exhibit increased goal-directed
activity which may mean excessive planning of and participation in multiple
activities. These can include social, employment, sexual and physical activities.
The patient's social interactions can often become intrusive, demanding and
domineering although this is usually not recognised by the sufferer. These
activities tend to have a disorganised, flamboyant or bizarre quality. The manic
patient also has a tendency to indulge in imprudent activities which have a high
risk component, often of a sexual or financial nature (Goodwin 1998). If the
patient's mood swings towards irritability rather than elation, he may exhibit
aggressive or even violent behaviour.
A patient suffering from a manic episode often does not recognise that he is ill and
will strenuously resist any efforts made to treat him. He will exhibit lability of
mood with rapid shifts between elation and expansiveness and anger and
depression. Occasionally the depressive and manic symptoms occur
simultaneously or alternate rapidly within a period of a few days.
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The patient may experience delusions and hallucinations during the period of
primary mood disturbance. The content of these is congruent with the predominant
mood.
4.2 Epidemiological Findings
DSM-IV reviews the prevalence of bipolar affective disorder and estimates it as
0.4% to 1.2 % of the adult population.
In bipolar disorder the sex incidence is roughly equivalent or shows a slight excess
of females. The peak age of onset is between 25 and 29 years of age with no sex
difference. Onset is rare before puberty, although symptoms may occur during the
teenage years when the diagnosis may be missed. It has been claimed that the
stability of its demographic characteristics favour primarily biological causes
(Goodwin 1998).
4.3 Genetics of Affective Disorders
Segman & Lerer (2000) suggest on the basis of twin studies that bipolar disorder
receives a greater genetic contribution than unipolar disorder. This suggestion
supports the pathogenic distinction between unipolar and bipolar disorder made on
the basis of neuropsychological data. Where twin probands had bipolar illness the
MZ concordance was found to be 72% and the DZ concordance 14%, whereas for
unipolar disorder the MZ concordance was 40% and the DZ 11%. Bertelsen et
72
a/.'s (1977) study based on the Danish National Twin Register found that the
MZ/DZ concordance rate is higher (almost 4:1) when the proband has bipolar
disorder than when the proband has unipolar disorder (just over 2:1).
Linkage analysis has been useful in identifying the chromosomal location of genes
for disorders such as cystic fibrosis and Huntingdon's disease and has also
produced encouraging results in genetically complex disorders such as bipolar
disorder (Potash and DePaulo 2000). Blackwood et al. (2001) in a review of
linkage studies of bipolar disorder in large families proposed that genes of a
relatively major effect can cause illness in single multiply affected pedigrees.
Bipolar disorder is likely to be genetically heterogeneous with mutations in one of
several independent genes producing a similar clinical phenotype. An alternative,
or perhaps additional, model is that clinical symptoms can be seen as continuous
variables, known as quantitative traits. These are produced by the additive or
interactive effects of mutations in two or more genes (Risch and Botstein 1996).
The notion is that each quantitative trait locus (QTL) only has a small effect on the
trait and symptoms develop due to the cumulative effects of mutations in several
genes, most probably combined with other environmental risk factors. Advantages
of studying a single large family include the fact that the influence of one or a few
genes will be dominant and detectable. However, a single family may express an
uncommon form of a disease and may not be applicable to the general population.
Blackwood et al. (1996) identified a locus for bipolar disorder on chromosome 4p
in one large bipolar pedigree and the phenotype will be examined in members of
that family in more detail in the present study.
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4.4 Cognitive change in Affective Disorders
4.4.1 Why study neuropsychology in affective disorders?
Until fairly recently, investigation of cognitive function in psychiatric illness
focussed mainly on schizophrenia and unipolar depression. One possible reason
for this may be that professionals are still influenced by the work of Kraepelin
(1913/1950) who felt that cognitive decline was associated with schizophrenia and
not bipolar disorder. However, Goodwin and Jamison (1990) estimate that
between 30 and 50% of bipolar patients fail to attain premorbid levels of
psychosocial functioning after remittance of illness, and that this may be due to
persistent cognitive impairment. Comparison of neuropsychological function in
bipolar disorder and other major mental illnesses may help to establish whether any
cognitive deficits are specific to bipolar disorder, and go some way towards
shedding light on the aetiology of the illness. Persistent cognitive dysfunction
outwith episodes of illness may then be considered to be trait rather then state
deficits.
4.4.2 Cognitive deficits in symptomatic patients
The major findings of cognitive impairment in depression have been covered in the
previous chapter. There are fewer studies which have attempted to address the
nature of impairments in mania. In their review of the neuropsychology of bipolar
disorder, Murphy and Sahakian (2001) suggest this may be due to the practical
difficulties of assessing patients with mania. However, patients with mania have
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been studied using tasks which assess aspects of learning and memory, visuospatial
ability and executive function. Taylor and Abrams (1986) conducted a study of
manic patients on tests of attention, visuospatial function and memory.
Approximately half of the sample demonstrated moderate or severe global
cognitive dysfunction. A more recent finding from Murphy et al (1999) showed
that bipolar patients in a manic state are impaired on tests of pattern and spatial
recognition memory and delayed visual recognition. The authors of the review
state that the notion that mania is associated with a dysexecutive syndrome seems
reasonable as patients generally exhibit disrupted social behaviour and decision¬
making similar to that seen in patients with lesions to the frontal cortex (Bechara et
al. 1994). There has been little work investigating these types of abilities in mania.
Morice (1990) and Clark et al (2002) have investigated attentional set-shifting,
Murphy et al (1999) have looked at planning ability and Clark et al. (2002) and
Murphy et al. (2001) have investigated decision-making. Impairments have been
observed in all these areas.
Much of the literature that has directly compared mania with depression suggests
that on tasks of attention, memory and executive function, patients with mania and
patients with depression are virtually indistinguishable. Bulbena and Berrios
(1993) investigated patients during acute episodes of mania and depression using
tests of attention, memory, visuospatial function and choice reaction time. When
compared with a healthy control group the patients were generally impaired but no
differences between mania and depression were found. Indeed, Goldberg et al
(1993b) found that bipolar patients who were either depressed or manic did not
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differ on the WAIS-R, WCST, or on neuropsychological tests of reading, line
orientation or facial recognition.
4.5 Cognitive deficits during remission
Previous work investigating cognitive functioning in bipolar disorder showed that
during periods of illness, patients experienced some cognitive difficulties but after
the clinical symptoms disappeared, many patients returned to their normal levels of
functioning. However, there is a body of evidence that reports that some bipolar
patients have cognitive difficulties after the remission of an acute episode, which
points to the existence of a subgroup of bipolar disorder patients who have a more
malignant form of the disorder. Savard et al. (1980) reported in a study with
limited numbers that acutely depressed bipolar patients have a marked cognitive
deficit on the Halstead-Reitan categories test, in which subjects must arrive at the
organising principle differentiating one visual stimulus from another three over a
number of trials, part of a battery of tests originally developed to distinguish brain¬
damaged from non-brain-damaged subjects. On retest in the improved state, some
bipolar patients continued to experience fundamental cognitive impairment outwith
periods of illness. A study by Tham et al. (1997) of twenty-six patients with
recurrent mood disorders found a remarkably lowered cognitive function in a
number of euthymic patients. A significant positive relationship between a number
of neuropsychological domains, including visual-constructive reasoning, general
intelligence and the Trailmaking Test for visuospatial scanning and flexibility, and
the number of hospitalisation episodes was found in remitted bipolar patients. The
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patients generally had an overall lowered performance compared to control data,
but patients with impaired cognitive functioning had experienced significantly
more hospitalisations than those with normal cognitive functioning. It is, however,
worth mentioning that no definition of 'euthymic' was given and mention made of
measurement of residual symptoms, and also that a matched control group was not
constructed for this study but rather data was drawn from a database of normal
controls.
Further support for persistent deficits in affective disorders comes from a study by
Addington and Addington (1997) who found that stable outpatient bipolars' visual
attention was not significantly different from controls, but neither was it
significantly different from schizophrenia patients. This suggests that there may be
some attentional impairment on tests which are considered to be vulnerability
indicators in schizophrenia, in that impairments are evident in high risk groups,
actively psychotic and remitted schizophrenic patients. It further suggests that
where there is an abnormal reduction in the availability of cognitive resources
when there is a high processing load resulting in difficulties remembering a target
whilst monitoring a stream of potential targets, deficits in information processing
are not specific to schizophrenia.
McKay et al. (1995) screened unipolar and bipolar patients during remission on a
battery of neuropsychological tests and found five bipolar patients with chronic,
severe illness were impaired on one or more measures. A more detailed
investigation showed a variable pattern of impairment ranging from verbal memory
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and executive function to widespread poor performance. These five patients were
from what the authors termed the chronic, severe group so it is unclear whether
these deficits occur as a direct consequence of long-term illness or whether they
could precede the onset of clinical illness. However, any conclusions drawn from
a sample size of five must be very tentative indeed. It must be noted, furthermore,
that a clinical judgement of euthymia was only backed up with ratings of
depression and not mania, and some rapid cycling patients were tested between
mood swings "when they were (sometimes only briefly) euthymic" (p52).
van Gorp et al. (1998) investigated cognitive impairment in twenty-five bipolar
disorder patients with and without prior alcohol dependence (whilst euthymic for at
least three months and not suffering from the effects of alcohol abuse). No
significant differences in visuospatial, nonverbal memory or psychomotor speed
abilities were found between the bipolar groups and controls, which suggests that
there is not a diffuse cognitive deficit, and also is not in keeping with previous
notions of a relative right hemisphere dysfunction in bipolar disorder (Flor-Henry
and Yeudall, 1979). However, both bipolars with and without a history of alcohol
abuse performed more poorly than controls on both long, short, free and cued
recall conditions and total number of words acquired on a test of verbal memory
(the California Verbal Learning Test). This suggests both acquisition and storage
difficulties. Patients with an alcoholic history achieved fewer categories on the
Wisconsin Card Sorting Test, an executive function task, which suggests that some
capacity has been lost to interrupt and change ongoing activity and adapt to new
rules. The authors found that for both bipolar groups, lifetime months of mania
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and depression were negatively correlated with performance on verbal memory and
executive function tasks. The conclusion that the authors drew from this relatively
small-scale study was that these deficits were due to disease process. It should be
noted that although medication effects could not entirely be ruled out, the authors
found no significant correlations between current lithium level and cognitive test
performance.
Ferrier et al. (1999) found that both 'good' and 'poor' outcome bipolar patients
(based on the number of affective episodes over the previous five years) performed
more poorly than controls on a number of neuropsychological tests, indicating
impairment of new learning and recall in both verbal and non-verbal domains,
impaired executive function and visuomotor speed and sustained attention. When
age, premorbid IQ and low level depressive symptoms were controlled for, the
results showed impaired executive function, specifically in tasks with a working
memory component and also involving set shifting and strategy generation,
suggesting difficulties with both reactive and spontaneous flexibility similar to that
described in schizophrenia. No differences were found between the 'good' and
'poor' outcome groups, but as these groups were arbitrary, it is difficult to draw
any conclusions about the relationship of neuropsychological functioning to
outcome. As with other studies of euthymic bipolar patients, the possibility of the
impairments being due to medication effects cannot be entirely ruled out.
However, the fact that this well-defined group of euthymic bipolar patients
demonstrated specific deficits even after controlling for residual symptoms
provides good evidence for a persistent deficit in the disorder, which the authors
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suggest may reflect frontal lobe damage or disruption of frontal circuits, although
this remains unclear, as does whether any neuroanatomic abnormalities are a
consequence of disease process or present before the onset of illness.
Kessing (1998) concluded from a controlled cohort study that neuropsychological
deficits in outpatients with unipolar and bipolar disorder seem to be associated with
the number of acute episodes of depression. However, there was a large difference
in sample size between the two affective disorder groups, with unipolar patients
outnumbering bipolar patients. Furthermore, all the bipolar patients had had more
than one episode, whereas almost half the unipolar patients had experienced only
one episode. However, no differences were found between the affective disorder
groups on cognitive function.
Cavanagh et al. (2002) tested the hypothesis that euthymic bipolar patients would
exhibit impairment in verbal learning and memory and executive function
compared to healthy controls matched for age, gender and premorbid IQ.
Impairments were found in cases compared with controls in aspects of the
California Verbal Learning Test, most notable in immediate recall, a measure of
global learning, and recognition. Verbal learning and memory were found to be
negatively correlated with the number of manic episodes. These results suggest
that impaired verbal learning and memory may be a trait variable in bipolar
affective disorder. However, it may be that these deficits are due to disease
process effects, and little work has been done investigating neuropsychological
performance in first episode bipolar affective disorder patients which would be
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informative in this matter. The inclusion in the present study of biological relatives
of bipolar probands at high genetic risk of developing the disorder will attempt to
differentiate trait versus disease process effects.
It has been a criticism levelled at several of these studies investigating bipolar
patients in remission that their clinical status is not well defined. This led
Rubinsztein et al. (2000) to carry out a case-control study with stringent clinical
criteria, with patients having to have been in remission for at least four months.
The results demonstrated that euthymic bipolar patients showed a relatively
specific impairment in visuospatial recognition memory. The study also included
tests of executive function on which accuracy was not impaired in the patients,
although response latency was abnormal. This study failed to resolve the
discrepancies in the literature about whether euthymic bipolar patients have deficits
in executive function, memory or both. A study by El-Badri et al. (2001) found
that young euthymic patients with bipolar affective disorder have significant EEG
abnormalities and cognitive impairments compared with control subjects of similar
age and premorbid IQ. Interestingly, there were no correlations between EEG and
neurocognitive results but significant differences between patients and controls
were more frequent in cognitive tests depending on manipulation of visuospatial
stimuli. The EEG abnormalities were marked in right temporoparietal area,
important for visuospatial processing. No relation to illness duration or age of
onset was found but the number of affective episodes was significantly related to
the degree of cognitive impairment. These results suggest that cognitive
impairments may be present throughout the disease process.
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Krabbendam et al. (2000) compared cognitive functioning in relation to white
matter lesions in bipolar disorder in remission and in schizophrenia. The results
indicated that euthymic patients with bipolar disorder have persistent cognitive
deficits which involve several domains, including memory (immediate and delayed
recall, but not recognition), speed and cognitive flexibility, and which were similar
to the deficits seen in the schizophrenic group. No relationship was found between
cognitive deficits and white matter lesions in either of the patient groups.
However, because of the estimated power of the analyses, the results must be
tentatively interpreted. These findings are in conflict with those of Fazekas (1989)
and DeCarli et al. (1995) who did find a relation between white matter lesions and
cognitive functioning.
Summing up recent work investigating the specific domains of memory and
executive function in remitted bipolar disorder patients, studies of verbal memory
in bipolar disorder have used different versions ofword lists, such as the California
Verbal Learning Test (CVLT), the Auditory Verbal Learning Test (AVLT) and the
Rey Auditory Verbal Learning Test (RAVLT). Recent studies finding impairment
in remitted bipolar disorder compared to controls include van Gorp et al. (1998)
who found that patients performed poorly on the CVLT and that this impairment
was associated with the number and duration of illness episodes. Patients with a
prior history of alcohol abuse performed more poorly still. Ferrier et al. (1999)
also found impairment in verbal memory compared to controls using a similar task,
the RAVLT. Interestingly, impairment was more pronounced in patients with
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fewer episodes and good inter-episode recovery. Krabbendam (2000) also found
poorer verbal memory in remitted bipolar patients compared to a healthy
comparison group when tested on the AVLT. There is therefore some evidence for
verbal memory problems and cognitive flexibility deficits on executive function
tasks. Evidence for nonverbal memory problems is less clear-cut.
As with schizophrenia, executive function in bipolar disorder has often been
measured using the WCST and verbal fluency, measures of reactive and
spontaneous cognitive flexibility and to some extent, organisation of the semantic
store. Ferrier et al. (1999) reported reduced verbal fluency performance compared
to controls in a group of remitted bipolar patients with residual depressive
symptoms, a finding which persisted even after controlling for group differences in
depressive symptomatology. Atre-Vaidya et al. (1998) found that their sample of
stable bipolar patients demonstrated verbal fluency scores below the normative age
corrected mean for this test.
On the basis of their recent review Quraishi and Frangou (2002) conclude that
deficits in executive function in bipolar disorder appear to be closely associated
with the presence of residual symptoms. Low level manic and depressive
symptoms seem to produce an increase in perseverative errors (Coffman et al.
1990, McGrath et al. 1997), verbal fluency (Ferrier et al. 1999) and planning ability
(Ferrier et al. 1999, Rubinsztein et al. 2000). Quraishi and Frangou (2002) also
conclude that whilst symptomatic, bipolar patients exhibit deficits on the WCST
comparable to those of schizophrenic patients, but when remitted they may
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outperform schizophrenics. They conclude that symptomatic bipolar patients have
widespread cognitive deficits, and that verbal memory may be a trait deficit.
Executive function may also be affected in at least some remitted bipolar patients.
Investigating the cognitive performance of MZ twins discordant for a
neuropsychiatric disorder allows for the examination of both clinical disease-
specific impairments (in the comparison of affected to unaffected twins) and
clinical risk factors (in the comparison of unaffected twins to normal twins).
Gourovitch et al. (1999) investigated intelligence, attention, visuospatial skills,
language, learning and memory and problem solving in MZ twin pairs discordant
for bipolar illness and normal MZ twins. The results showed that the affected
twins were significantly impaired in some visuospatial and verbal memory
measures compared with unaffected and normal twins. However, the unaffected
twins performed significantly worse than normal twins on a memory task and
verbal list learning. This suggests that while some deficits may be features of
bipolar disorder associated with the clinically apparent disease process, mild
deficits in overall verbal learning and retrieval function may be a genetic marker of
risk for the disorder. Although the results should be interpreted somewhat
tentatively due to the fact that only seven pairs of twins were included in the study
(although this may be due to the difficulties inherent in finding MZ twins
discordant for bipolar disorder), the presence of cognitive deficits in asymptomatic
individuals, as with patients at the onset of illness, may agree with other studies
showing that, as in schizophrenia, neurodevelopmental factors play a role in the
aetiology of bipolar disorder.
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A clearer picture is needed to attempt to establish whether any persistent deficits
displayed by bipolar patients are a function of the disease process or are trait
variables. If persistent cognitive deficits can be observed in remitted or euthymic
bipolar affective disorder patients, this suggests that such deficits could be
considered to be trait rather than state dependent, especially if it can be shown that
they are not due to symptomatology or medication. Investigation of cognitive
function would be useful in defining the phenotype and in the search for
endophenotypes in healthy biological relatives of patients.
4.6 Comparison of unipolar and bipolar disorder
A study comparing the neuropsychological performance of patients with bipolar
and unipolar disorder during an acute depressive episode was conducted by
Borkowska and Rybakowski (2001) who found greater cognitive impairment
(measured by tests of executive function including the WCST, verbal fluency,
Stroop and Trails A and B) during an acute depressive episode in bipolar compared
with unipolar patients. The differences between bipolar and unipolar patients were
not explained by symptom severity or duration of the illness and the pattern and
extent of abnormalities connected with frontal lobe function pointed to differences
in pathology between bipolar and unipolar affective disorder. The authors further
concluded that pronounced deficits in working memory and executive function
suggest similarities between bipolar disorder and schizophrenia, particularly as
there is evidence that in bipolar illness, as in schizophrenia, cognitive disturbance
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may already be present during the first episode of the illness (Yurgellun-Todd et al.
2000, Murphy et al. 2000). There are some limitations to this particular study, in
that a relatively small bipolar group was recruited and there was an unequal
distribution of gender in both groups. However, no differences were found
between males and females in either group. It is also difficult to conclude whether
the patient groups were performing at an abnormal level as no control data was
provided.
Paradiso et al. (1997) compared the cognitive performance of chronic unipolar
depression and bipolar disorder patients in remission with a normal comparison
group. Results indicated that unipolar depressive patients demonstrated cognitive
deficits on measures of visuo-motor sequencing, executive function and immediate
memory and attention. These deficits are consistent with a prefrontal-type
syndrome. Remitted bipolar patients, however, showed mild deficits in some
cognitive measures relative to controls but these did not reach statistical
significance. This may be due to the small sample size (eleven patients). The
authors suggested that in the light of these findings patients with unipolar and
bipolar disorder should not be considered as have a unitary disorder.
4.7 Neuropsychological deficits in bipolar disorder compared with
schizophrenia
It has been assumed previously that deficits such as those described in the
preceding chapter are specific to schizophrenia. However, this may not be the
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case. Hoff et al. (1990) investigated 35 patients with a diagnosis of bipolar
affective disorder, manic type, and 30 patients with schizophrenia tested on a
comprehensive neuropsychological test battery including tests on verbal learning
and memory, executive function, visuo-spatial memory and psychomotor speed.
This study failed to differentiate between schizophrenic and bipolar patients on
measures of verbal, spatial and speed variables with age, sex, education, duration
of illness, number of hospitalisations and medication at the time of testing
controlled for. This then refutes previous notions that schizophrenia and bipolar
disorder have lateralised deficits in the left and right hemispheres respectively.
Hoff et al. concluded that this failure to discriminate between the two patient
groups may relate to indications that bipolar patients also have abnormalities in
brain morphology. Morice (1990), from a study of 60 schizophrenic patients, 20
bipolar (manic) patients and 34 non-patient controls tested on the Wisconsin Card
Sort Test, concluded that cognitive inflexibility and/or prefrontal dysfunction may
not be specific to schizophrenia as bipolar patients who were both recovering from
an acute episode and those in remission had an equivalent level of performance to
schizophrenics. Morice concluded that problems with cognitive inflexibility
suggest some level of dysfunction of the prefrontal cortex in both schizophrenia
and bipolar disorder.
Berrettini (2000) has suggested that on the basis of recent genetic studies showing
a degree of overlap in familial risk, in that relatives of bipolar probands are at
increased risk for recurrent unipolar, bipolar and schizoaffective disorders and that
relatives of probands with schizophrenia are at increased risk for schizophrenia,
87
schizoaffective and recurrent unipolar disorders, there may be some shared genetic
susceptibility and that consequently the disorders may not be as distinct as current
diagnostic systems suggest. Keri el al. (2001), working on the basis of this
evidence, investigated performance on cognitive measures often found to be
affected in patients with bipolar disorder and schizophrenia in biological relatives
of probands with these disorders. Although dysfunction in sensory-perceptual
analysis (revealed by a visual backward masking task) and spatial working
memory distinguished relatives of schizophrenic patients from relatives of patients
with bipolar disorder, both groups displayed deficits in verbal recall, suggesting a
common impairment of the fronto-hippocampal system. The cognitive battery
employed in this study was fairly limited, and utilized a relatively small sample
size, but this was however determined by strict selection criteria, using high-
functioning individuals to minimize confounding factors. This does then make the
finding of cognitive abnormalities in high-functioning well relatives of probands
very interesting.
Murphy and Sahakian (2001) have reviewed several studies that have compared
neuropsychological performance in mania and schizophrenia. Findings from these
studies show that on tests of selective attention (Oltmanns, 1978), perceptual span
(Strauss et al. 1984) and shifting attentional set as measured by the WCST (Morice
1990), patients with mania and those with schizophrenia are virtually
indistinguishable. A study by Otteson and Holzman (1976) compared
schizophrenics, non-schizophrenic psychotic patients and non-psychotic patients
with each other and with a healthy comparison group on a variety of
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neuropsychological tests. Group differences were apparent between psychiatric
patients and controls and between patients with and without psychosis. However,
there were no differences between the schizophrenic and manic groups.
Differences appeared to be related to degree rather than type of disorganisation.
Differences between manics and schizophrenics have also been reported, however.
Andreasen and Powers (1974) found overinclusive thinking to be more prominent
in mania than schizophrenia and Goldberg et al. (1993b) reported that
schizophrenic patients performed more poorly than patients with affective disorder
(unipolar depression, bipolar depression and bipolar mania) on tests of
psychomotor speed, attention, memory and attentional set-shifting. However the
schizophrenic group showed greater intellectual deterioration. It should be noted
that the bipolar disorder group included in this study was quite small, so there may
be power implications. Murphy and Sahakian (2001) have further suggested that
the cognitive deficits observed in bipolar depression could be unrelated to similar
impairments in unipolar depression.
Bearden et al. (2001), in their review of the neuropsychology and neuroanatomy of
bipolar disorder, state that generally, when symptomatic, cognitive abilities in
bipolar patients appear to more closely resemble those of schizophrenic patients.
The question is, given the recent findings of enduring deficits in bipolar disorder;
do the similarities between the disorders persist?
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4.8 Neuroimaging findings in affective disorders
There has been considerable number of both structural and functional imaging
investigations in affective disorder. Soares and Mann (1997a) reported in their
review reported that structural abnormalities in basal ganglia, frontal lobe,
temporal lobe and cerebellum. They claim that this suggests the presence of
regional atrophy. It is further reported that the pattern of abnormalities
distinguishes between unipolar and bipolar disorders, as unipolar patients smaller
frontal lobes and bipolar patients additionally have abnormalities in the temporal
lobe. The possibility that different brain structures are involved in unipolar and
bipolar disorder is consistent with a biological distinction in the pathophysiology
of these disorders. An increased frequency of signal hyperintensities has also been
reported in the brains of both unipolar and bipolar patients, although in unipolar
depression these seem to be more apparent in elderly patients (Coffey et al. 1989).
A recent meta-analyses of MRI findings in patients with affective disorders
reported that these signal hyperintensities are often localised in the frontal lobes
and basal ganglia, which is suggestive of a basal ganglia/frontal circuit impairment.
It has also been reported that these abnormalities are correlated with the cognitive
impairment observed in unipolar and bipolar disorder (Videbech, 1997).
Videbech's recent meta-analysis further concluded that age of onset seems to be
less significant in bipolar patients displaying signal hyperintensities, as there is
evidence of them in younger and first episode patients (Strakowski et al. 1993;
Botteron et al. 1995), whereas normally they are associated with ageing. He
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further speculated that this may be due to the relatively greater importance of
genetic factors in bipolar disorder.
The prefrontal cortex has been implicated in control of willed action, working
memory, inhibition, motivation and mood regulation (Soares and Mann 1997b).
The findings of decreased blood flow and metabolism would suggest that it is
important in the development of affective disorders.
Another main area of structural and functional abnormality is that of the basal
ganglia. There is evidence of functional abnormalities in unipolar disorder, and
perhaps also for bipolar disorder. Soares and Mann (1997b) outline a hypothetical
neural circuit connecting basal ganglia structures with medial temporal structures
such as the amygdala and hippocampus, which in turn have connections with the
prefrontal cortex, whereby damage to the circuit may result in depression.
The temporal lobe may also be dysfunctional in bipolar disorder and possibly also
in unipolar disorder, and the importance of this in affective disorder may be related
to abnormalities in the limbic structures found in the temporal lobes. It is not clear
what the cause of this dysfunction is, but as Soares and Mann (1997b) suggest, it
may be that genetic and environmental factors interact with the structures
implicated in bipolar disorder in ways which are not yet clear.
Bearden et al. (2001), undertaking an extensive review of the neuroimaging
literature, in an attempt to delineate the most consistently reported structural brain
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abnormalities and to determine whether any were specific to bipolar disorder,
concluded that significant cognitive impairment may be present and that these may
correlate with signal hyperintensities in the frontal lobes and basal ganglia,
associated with executive function, attention, learning and memory and affect
regulation. Little evidence was found for a selective right hemisphere dysfunction
as had previously been supposed on the basis of earlier reports of relatively greater
impairment of visuospatial function, literalised abnormalities and mania secondary
to right hemisphere lesions. They further conjectured that the overlap in
abnormalities in brain structure and function in schizophrenia and bipolar disorder
could be caused by similar anomalies in gene expression affecting development in
both patient groups. This suggests the need for neuroimaging studies in high-risk
populations.
There are problems inherent in reviewing neuroimaging data, principally in
selection and definition of patient groups and controls, but also with different
methodologies employed in the imaging studies themselves. However, the data
would suggest that there are some consistently reported structural and functional
abnormalities, and that they seem to be correlated with findings of cognitive
impairment in affective disorder.
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4.9 Neurophysiological changes in affective disorders
There has been less investigation of auditory P300 in affective disorders than there
has in schizophrenia. Auditory P300 amplitude has been found to be reduced in
depression (Diner et al. 1985). Some studies have indicated that the amplitude of
event-related potentials in depression are related to clinical state (Blackwood et al.
1987; Gangadhar et al. 1993). A large-scale study of auditory P300 in affective
disorders was conducted by Muir et al. (1991) comparing patients with bipolar
depression and unipolar depression with psychiatric in-patient and normal controls.
The results showed that the latency of P300 was significantly greater in
schizophrenic and bipolar patients than in any of the other groups. The differences
were not due to age, state or medication and support the distinction between
unipolar and bipolar depression as P300 did not distinguish between unipolars and
controls. This finding of prolonged P300 latency in bipolar depression compared
with controls was replicated by Souza et al. (1995).
Eye movement disorder has been suggested to be such a biological risk factor in
bipolar disorder and schizophrenia. When a slow moving object is visually
tracked, the neurological control of eye movements involves both the smooth-
pursuit eye tracking system and higher frequency saccadic movements. It has been
established that some schizophrenics have impaired smooth-pursuit and similar
impairments have been reported in affective illness. However, the eye-movement
abnormalities found in bipolar disorder patients differ from those found in
schizophrenia (Abel et al. 1992) and there is some evidence to suggest that
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although it is seen in relatives of schizophrenic probands it is less common in
relatives of bipolar patients (Holzman et al. 1984).
Although not conclusive, these data are suggestive of a possible stronger
relationship between bipolar disorder and schizophrenia, rather than between
bipolar disorder and unipolar disorder.
4.10 Description of a pedigree showing evidence of linkage of
bipolar disorder to a locus on chromosome 4
Blackwood et al. (1996) identified a large extended family multiply affected by
bipolar and unipolar disorder in which linkage between markers and disease was
reported on the short arm of chromosome 4. In this pedigree, Family 22, clinical
and genotype data have been obtained from 120 individuals, including eleven with
bipolar disorder and sixteen with recurrent major depression. This analysis
identified a haplotype, a set of closely linked genetic markers, present on
chromosome 4 which is inherited by all bipolar family members and fourteen of
the sixteen unipolar relatives. The resulting LOD score (greater than 4) confirmed
significant linkage between these markers and affective illness. In Figure 1, the
alleles of the chromosome 4 markers D4S431, GATA22g05, D4S1582, D4S1605,
D4S1599 and D4S403 are shown. The chromosomes represented by alleles
2441238 are inherited from their parents by all relatives with bipolar disorder and
by 14 of 16 with unipolar depression. In this family, some relatives are "high risk"
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with no symptoms. Relatives with the disease-related haplotype have a forty-fold
increased risk of developing an affective disorder (Visscher et al. 2001).
This family offers a unique opportunity to study the relation between
neuropsychological deficits, clinical symptoms and genetic risk in bipolar illness.
By studying members of a single family it is expected that genetic heterogeneity
will be minimised and variation in environmental influences will be reduced.
Genetic risk can be accurately measured and high risk individuals detected by their
genotype. Therefore comparison of three groups will permit a separation of effects
of genetic risk and effects of symptoms. The three groups are 1) relatives with
symptoms and disease haplotype, 2) relatives without symptoms and with disease
haplotype and 3) relatives without disease haplotype.
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Recent dramatic advances in molecular genetics and the completion of the
sequencing of the human genome have highlighted the need for ethical guidelines
for research with a genetic component related to mental disorders. This need was
recognised by the Nuffield Council on Bioethics which published a report (1998)
with a major aim of identifying and defining ethical questions raised by recent
advances in biological and medical research in order to respond to, and to
anticipate, public concern.
The areas of bioethics that have most practical relevance and are important to the
projects described in this thesis are those relating to informed consent, the role of
ethics committees, the role of the individual researcher, and confidentiality of
information about individuals taking part in genetic research projects (Meslin
1997).
Farmer et al. (2000) stress that participants in all types of genetic research should
be fully informed and need to understand the likely benefits, risks and alternatives
to participation in a study. One ethical concern is that the research may cause non-
physical harm. Several types of possible misconceptions about research may
require clarification. Participants may fail to recognise the difference between
testing that may inform treatment and non-therapeutic testing done for research
purposes only. Furthermore, relatives of patients may expect that by participating
in such research, they will learn more about their own susceptibility for developing
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mental illness. The presence of 'susceptibility' genes does not necessarily mean
that an individual will develop the disorder. Consent forms must therefore be very
clear in stating whether or not participants can expect any benefits from the study
and if not the consent form must state clearly that participation is only for the
benefit of scientific and medical knowledge.
A particular issue is how to gain informed consent from people with major mental
disorders, who are a vulnerable group who may have reduced capacity to
understand the purposes of research. The Nuffield Council on Bioethics Report
(1998) states that an important principle in ethics is respect for human beings and
their autonomy and dignity, and that this principle underlies the legal requirement
to seek consent. Even at its worst, mental disorder rarely results in comprehensive
incapacity, and most people suffering from a mental illness can continue,
throughout the duration of their disorder, to take decisions for themselves.
Therefore individuals with mental illness have capacity (as legally defined) to give
informed and genuine consent to participate in research, unless it can be shown
otherwise, and are not any different in their capacity to understand and agree to
participate in research from people suffering from other types of illness. In
determining whether someone has the necessary capacity to decide whether or not
to participate in a research study, it must be established that the person possess the
capacity to make a choice; understands what the study aims to do and why it is
being done; understands what participation will involve; understands any benefits
or risks, or in the case of non-therapeutic research, that there are no direct benefits;
and understands the consequences of not participating, or it is made clear that non-
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participation will not affect any treatment that they , or in the case of unaffected
family member their relative, may receive, as is the case in this study. In Scotland
this issue has recently been clarified by the Scottish Executive, one of whose first
actions was to draft the "Adults with Incapacity Act" laying down the legal rules
for research on patients including the mentally ill and those with dementia who
may have limited capacity to understand the technical details of a research project.
When seeking consent, respect should be given to an individual's capacity for
understanding and time should be allowed for them to ask questions. In this study,
a written information sheet was provided and consent forms and information sheets
conformed to the guidelines proposed by the Scottish Executive.
The principles by which research proposals are scrutinised are enshrined in the
Nuremberg Code (1949). This states that participants in research should give
voluntary consent, not be subjected to suffering and that the work will produce
"fruitful results for the good of society, unprocurable by other methods or means of
study". The implication is that in order to be ethical, research must also be
methodologically sound. Farmer et al. (2000) pertinently comment that a major
problem for ethics committees is to be able to judge the merits of a study given the
rapidly changing nature of the field, so expert opinion should be obtained.
The nature of genetic research means that information is often required from
unaffected family members. It is a given that relatives should not be approached if
the proband refuses permission. In this study, contact was made with relatives
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only after consent was given by the proband. Key family members then contacted
other family members who were then approached by the research team after
consultation with their General Practitioner. This family has previously given their
consent to be involved in a genetic linkage study and many relatives had indicated
willingness to participate in further studies including neuropsychological testing.
Another issue that arises when working with unaffected family members in genetic
research is that of how their perception of the illness can be changed by
participation in a study. It may be the case that family members are unaware that
illnesses such as depression may have a genetic basis and researchers have to
accept the role of educators. Confidentiality is also a major concern. Participants
may reveal information to researchers that they would not wish the rest of the
family to know, so confidentiality must be strictly preserved. A general area of
concern when considering genetics and mental health is the use that may be made
of and individual's genetic information. A unique aspect about genetic information
is that it is likely to be common to, and therefore of relevance to, other family
members. This raises a peculiar issue about confidentiality, concerning who
should have access to genetic information derived from one person if it is relevant
to another family member, if the person does not want it to be disclosed. As the
Nuffield Council on Bioethics Report (1998) states, it must be a matter for the
individual concerned to agree to the disclosure of their genetic information, unless
very strong public interest justifications exist. If such confidentiality is not
assured, people will no longer consent to be involved in such studies. One further
issue concerning confidentiality which is of particular importance to the current
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study is that when using the genetic information in research, it is of paramount
importance that inadvertent disclosure is guarded against and no identifying
information is published (Parker 2002).
Genetic information about people with mental disorders may affect how others
view people suffering from mental illness, and in particular raises issues about
stigma. Stigma often originates from ignorance and misconceptions about mental
illness. Jorm et al. (1997) found that over half the respondents in a large survey
were inclined to blame people with mental disorders for their condition. Stigma
also affects the families of people with mental illness, in that they may be viewed
as 'tainted' or be blamed for the illness. Stigmatisation can make mental illness an
object of fear and thus deter people from seeking help when they suffer from it.
Farmer et al. (2000) suggest that increased understanding of the genetics of mental
illness may lead to a reduction in stigmatisation. They cite examples of parents
whose offspring suffer from schizophrenia who are reassured that the illness has a
substantial genetic component and is not the result of poor parenting, and the fact
that the stigma associated with Alzheimer's disease has reduced as understanding
of the biological basis of the illness has increased. However, the Nuffield Council
on Bioethics report (1998) argues that linking mental illness with genetic
differences might reinforce the notion of fundamental differences between people
with mental illness and 'normal' people.
Genetic research on complex conditions with genetic and environmental
components such as bipolar disorder present special ethical issues. However, as
101
scientific advances are made, the debate is still some way from reaching a final
conclusion.
In this study these ethical concerns were dealt with as follows:
1. First contact with relatives of probands was made by the proband and not
by a researcher.
2. All prospective participants were given a detailed information sheet and
had time to ask questions about the project before signing the consent form.
3. The consent form included a statement that information was confidential,
that no clinical or genetic information would be fed back to participants and
that participation in the study would not affect treatment in any way.
4. The study was reviewed and approved by the local Ethics of Medical
Research Committee (Psychiatry and Clinical Psychology Research Ethics
Sub-Committee of Lothian Health Research Ethics Committee).
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6.0 AIMS OF THE STUDY AND HYPOTHESES
6.1 Aims
The first part of the study was designed to measure memory and executive function
in groups of patients with schizophrenia, bipolar disorder and unipolar depression
and healthy controls to measure the extent and nature of impairment in each of
these subject groups and to compare results between groups, as previous work has
produced conflicting results. There is clear evidence for impaired memory, both
verbal and to some extent nonverbal, and executive function deficits of the reactive
and spontaneous flexibility type in schizophrenia. There is now growing evidence
for a similar pattern of impairment in symptomatic and perhaps euthymic bipolar
patients also. The effects of medication and symptom severity on cognitive
performance were analysed. The purpose of this was principally to determine
whether impairments previously described in bipolar disorder patients during
remission could be replicated. If so, this would suggest that such deficits are trait
rather than state dependent and may therefore be useful in defining the phenotype
in the disorder. In comparing bipolar patients with schizophrenic patients, the aim
was to assess whether the deficits that can make the two groups indistinguishable
during episodes of illness persisted upon recovery. Comparing remitted unipolar
patients with remitted bipolar patients aimed to assess whether the bipolar group
exhibited impairment where the unipolar group did not. Based on the review of the
literature showing that bipolar patients may show similar deficits to those exhibited
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by schizophrenia sufferers, it was hypothesised that the schizophrenic group would
be impaired relative to controls and the bipolar group would exhibit similar
impairments to the schizophrenic group. The evidence for a distinction between
unipolar and bipolar disorder in addition to the literature showing that cognitive
impairment in unipolar affective disorder may be more state than trait dependent
leads to the hypothesis that the unipolar group would not show the pattern of
deficits found in bipolar and schizophrenic patient groups but would be similar to
controls.
The second part of the study was an analysis ofmemory and executive function in
the single large family (Family 22) that showed linkage of affective disorder to
chromosome 4. Within-family comparisons were made between relatives carrying
high and low genetic risk. If the population group of bipolar disorder patients
show deficits in memory and executive function unrelated to clinical state or
medication status, it may be that these are trait changes and related to genetic
aetiology of the illness, rather than an effect of disease process. Therefore it was a
hypothesis that family members carrying high genetic risk will demonstrate
similar, perhaps milder, deficits even though they have never shown symptoms of
bipolar illness. This would then suggest that neuropsychological impairment could
be useful in investigating the relationship between the observable phenotype and
the genetic background. The identification of such endophenotypes may facilitate
molecular genetic research to find genes responsible for the transmission of
vulnerability to bipolar affective disorder.
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6.2 Hypotheses
The hypotheses proposed and tested were that:
1. Significant between group differences in memory and executive function
will be observed between the schizophrenia and control groups and
between the bipolar and control groups, and not between the unipolar and
control groups.
2. The degree of neuropsychological impairment in schizophrenia and bipolar
disorder will not correlate with medication, age, sex or symptom severity at
time of testing.
3. Members of the Family 22 kindred with illness linked to a locus on
chromosome 4p will manifest deficits in memory and executive function
similar to those observed in the unrelated bipolar disorder group.
4. In Family 22, deficits in memory and executive function will be measured
in "high risk" relatives who carry the disease-related haplotype but have no




7.1 Rationale and Aims
The aims of the study were (1.) to examine the effects of major psychiatric illness
on the psychological responses of schizophrenic, bipolar and unipolar affective
disorder patients in comparison with a group of population control participants and
(2.) to examine neuropsychological performances of members of Family 22, a
large family with several members affected with major mental illness. The study
of a single large pedigree whose members could be classified as "high risk" or
controls on the basis of genetic markers has several advantages for dissecting the
influences of symptoms and medication from genetics. From our knowledge such
an approach has never before been feasible or attempted.
Neuropsychological tests were selected for their ability to measure a specific
psychological function, primarily in the domains of memory and executive
function as highlighted by existing research.
7.2 Design
Neuropsychological data were generally collected within one session lasting
between one and two hours. In a few cases, patients became tired, inattentive or
uncooperative before testing had been completed, and testing had to be carried
over for another day. Participants were interviewed at various locations including
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the Royal Edinburgh Hospital, day units around the city and in participants' own
homes. Participants were assessed with the Hamilton Rating Scale for Depression
(Hamilton, 1960), the Beck Depression Inventory (1961), the Modified Manic
Rating Scale (Blackburn et al. 1977) and Brief Psychiatric Rating Scale (Overall
1983) for psychosis in schizophrenia to measure symptom severity at the time of
testing.
7.3 Participants
Twenty-six patients with schizophrenia, thirty-six with bipolar affective disorder,
forty one with unipolar affective disorder and thirty-one controls formed the study
groups. From the single large family with several members affected by major
psychiatric illness (see Blackwood et al. 1996), fifteen were identified as having
the haplotype and six did not. Five family members who were approached
declined to participate. The patient groups were recruited from inpatients and
outpatient clinics and day hospitals around Edinburgh. The control group was
recruited from hospital staff and members of the general public.
Criteria for Selection
The patients were selected to be approached for inclusion in the study after
examination of their case notes and after consultation with members of the medical
team involved in their care. The patients met DSM-IV criteria for a diagnosis of
affective disorder or schizophrenia and had no history of drug or alcohol abuse,
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head injury with loss of consciousness, epilepsy or stroke. Family members were
already part of an ongoing study of the genetics of bipolar disorder. The control
participants had no history of psychiatric disorder and no physical or neurological
illness reported by screening questions at interviews. All participants were aged
between 18 and 70. Diagnoses were made by a trained psychiatrist according to
DSM-IV criteria and were based on casenote reviews, discussion with medical
staff and completion of the semi-structured interview The Schedule for Affective
Disorders and Schizophrenia - Lifetime Version (SADS-L, Spitzer and Endicott
1978). All participants gave informed consent. Ethical approval for the study was
sought from and granted by the local area research ethics sub-committee.
7.4 Measures and Rating Scales Used
The measures used for severity rating and psychological tests were established and
validated tests which have been previously used in research and clinical practice.
This enables comparisons to be made with other studies and replication of this
study.
7.4.1 Severity Rating Scales
7.4.1.1 Hamilton Rating Scale for Depression (HRSD)
The HRSD (Hamilton 1960) is based on a factor-analytic study based on 272
depressed in-patients. It was revised in 1967. Its main purpose is to provide a
simple way of assessing the severity of a patient's depression quantitively and
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showing changes in the condition. The HRSD is an observer rating scale and has
become a standard instrument for depression ratings. It is completed after a
clinical interview and takes account of information from all sources concerning the
patient's behaviour during the previous week.
The full scale consists of 21 items. The scores are added to give a total score
measuring severity of depression. Each of the items is scored on a 3 (0-2) or 5 (0-
4) point scale for its intensity or frequency.
The reliability has been found to range from 0.81 (Prusoff et al. 1972) to 0.90
(Hamilton 1972) between raters at the same interview. The validity of the scale as
assessed by its correlation with other instruments for measuring depression ranges
from 0.79 to 0.82 (Brown and Zung 1972). The scale is sufficiently brief to allow
easy completion but yet is reasonably thorough.
7.4.1.2 The Beck Depression Inventory (BDI)
The original version of the BDI was introduced by Beck et al. (1961) and revised
in 1971. The Beck Depression Inventory is a 21 item self-report rating inventory
measuring characteristic attitudes and symptoms of depression. The depression
rating is obtained by adding the scores for each of the twenty-one questions. The
highest score on each question is three, and the highest possible for the whole test
is sixty-three. The lowest possible score for the whole test is zero. The BDI takes
approximately ten minutes to complete and the content was obtained by consensus
from clinicians regarding the symptoms of depressed patients. The inventory is
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prone to halo effects in that subjects' general attitude can influence responses to
many of the items and there is uncertainty as to what is actually measured (Dennis
etal. 1992).
Internal consistency for the BDI ranges from 0.73 to 0.92 with a mean of 0.86
(Beck et al. 1988), and a split-half reliability co-efficient of 0.93. Beck et al.
(1961) did not recommend conventional test-retest reliability for the original
measures for the inventory. Beck suggested that if the BDI was re-administered
within a short interval the scores could be spuriously inflated due to memory
effects. If the test was re-administered after a long interval then consistency would
be lower due to the intensity of the depression. Alternate test-retest reliability
methods by Beck et al. (1961) found that regardless of the test was reissued at two
or six week intervals, the scores on the inventory tended to reflect changes in the
clinical depth of depression. Groth-Marnat (1990) reported moderate correlations
between the BDI and other scales measuring depression such as the HDRS (0.73).
7.4.1.3 The Modified Manic State Rating Scale (MMRS)
The MMRS (Blackburn et al. 1977) is a version of the Manic State Rating Scale
which was developed by Beigel and Murphy (1971). The MMRS was developed
to meet the lack of specific rating scales of mania relative to those measuring
depression and to provide information about the diversity of manifestations of
mania, the relative remission rate of different symptoms or the relationship of
mania to depressive illness and other psychiatric states. An observer rated scale
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was necessary because of the inability of patients to rate themselves due to lack of
insight.
Shortcomings of the Manic State Rating Scale included lack of agreement on
definitions of symptoms, and confusion between related but separately scored
items. It also omitted certain important aspects of manic behaviour such as sleep
disturbance. The MMRS condensed related items and added other symptoms and
signs to produce a scale of 28 items. Each item is scored from 0 (absent) to 5
(continuous and gross). Information for scoring each item is obtained by
interviewing the patient, asking ward staff for information and by observing the
patient. Reliability and validity measures were provided by the authors who
conducted a study on sixteen manic in-patients. Ratings of the patients using the
MMRS were administered every two weeks, as were analogue ratings of mania by
staff. Each patient was rated independently by three raters, after an interview by
one of the raters using the Present State Examination. The overall correlations
between each pair of raters was 0.85, 0.79 and 0.81. All the individual items
except iooks depressed' significantly correlated with the total score. Validity, as
estimated by comparing the MMRS ratings with the analogue ratings of the
medical staff was computed as r=0.654 to 0.801 for all ratings.
7.4.1.4 The Brief Psychiatric Rating Scale (BPRS)
The Brief Psychiatric Rating Scale provides clinicians with a method for the quick
assessment of major dimensions of psychopathology. The original measure was
interview-based and consisted of sixteen items, although it has since been
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expanded to its present eighteen-item form (Overall 1983). The scale items were
designed to cover a broad range of symptoms and were based on factor analytic
studies and clinical expertise (Overall 1983, Overall and Gorman 1962). The scale
is commonly used for the diagnosis of and evaluation of treatment for severe
psychopathology and is most widely used with schizophrenic patients (Schutte and
Malouff 1995). The scale is administered by the mental health professional during
interview with the patient, with each of the eighteen items being scored on a 7-
point scale of severity. A rating of zero on any item indicates an absence of that
symptom.
Hedlund and Vieweg (1980) reviewed a number of studies investigating the
reliability of the BPRS and found that the median interrater reliability for the total
psychopathology score was .85. Flemenbaum and Zimmerman (1973) investigated
the test-retest reliability and found that for each of the eighteen items, three- to six-
month test-retest reliability ranged from near zero to .91.
Schutte and Malouff (1995) report that numerous studies have confirmed the
validity of the BPRS and that it has become a standard rating instrument for





The National Adult Reading Test (NART) (Nelson and Willison 1991) was
developed to assess impairment in intellectual functioning in dementia. Until its
development, the method of estimating deterioration in functioning was to compare
'hold' and 'non-hold' tests. However, this was rather unsatisfactory due to the
widespread abilities which different individuals demonstrate.
Nelson and McKenna (1975) showed that word reading ability and general
intelligence were highly correlated (r=0.75) in a group of 98 normal adults using
the WAIS full scale IQ and the Schonell Graded Word Reading Test (GWRT)
score. A regressive equation was extracted from the normative data to enable a
WAIS full scale IQ to be predicted from the GWRT score. Testing a group of
dementing patients showed that word reading ability was well maintained.
Nelson found that the GWRT did not contain enough difficult items to produce a
reliable estimate of the higher IQ levels. On the basis of this, the NART was
constructed and standardised. The NART aims to provide an estimate of
premorbid IQ levels by providing a sensitive measure of previous familiarity with
words. All the words contained in the NART are irregular and therefore their
pronunciation cannot be inferred from phonetic knowledge but only from
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familiarity. The NART consists of fifty words presented in order of increasing
difficulty.
The words are selected from an initial list of one hundred and forty irregular words
used in a pilot study with 25 non-dementing patients with extra-cerebral disorders
and ten relatives of out-patients. The NART was standardised using 120 in¬
patients with extra-cerebral disorders. Seven WAIS subtests and the GWRT were
also administered. The reliability of the NART was assessed by a split-half
technique (Cronbach alpha) which gave a reliability coefficient of 0.93.
Nelson and O'Connell (1978) administered the NART and the GWRT to forty
patients with bilateral cortical atrophy. The atrophy group had a lower mean
WAIS score than the 120 patients used in the standardisation study. The two
groups scored closer in the NART than in the GWRT, suggesting that the NART is
more resistant to the effects of the dementing process.
The NART is a relatively quick test to administer and does not demand close and
prolonged attention or motivation. Nelson reported that it is suitable for depressed
and other psychiatric patients. Although the data are not available for NART
scores with different psychiatric illnesses, Nelson stated that "there is no reason to
suppose that word reading ability would be impaired by psychiatric disorders".
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7.4.2.2 Current IQ
The Weschler Adult Intelligence Scale - Revised (WAIS-R) (Weschler 1981) has
become a widely used measure of intellectual abilities and impairment and is made
up of eleven subtests. Due to time constraints in testing it was not possible to
administer the complete scale and so selected subtests were used. Crawford et al.
(1992) evaluated a variety of short forms of the WAIS-R in terms of their validity
in predicting full-length IQ and in terms of their clinical utility. The authors used a
representative sample of the UK adult population to whom they administered the
full-length WAIS-R. They then built regression equations to predict full-length IQ
from the short forms. They concluded that short forms have a valid role in the
initial screening of subjects to provide a broad estimate of current intellectual
abilities. As Crawford et al. (1992) state, choosing between the different short
forms available is generally a matter of personal preference. However, a two-
subtest short form is unlikely to prove sufficient. The authors found that six- and
seven-item versions provided the best predictors of full-length IQ. However, given
the length of the test battery employed in the present study, it was felt that
Crawford's own four-item version comprising Block Design, Similarities, Object
Assembly and Comprehension, gave a satisfactory estimate of full-length IQ and
superior factorial validity. A measure of current IQ in addition to premorbid IQ




7.4.2.3.1 The California Verbal Learning Test
The California Verbal Learning Test (CVLT) (Delis et al. 1987) measures both
recall and recognition of word lists over a number of trials. It first assesses the
individual's ability to recall a list of 16 words (four words each from each of four
semantic categories) over five trials. An interference list of sixteen words is then
presented for one trial, immediately followed by free and category-cued recall of
the first list. The two lists are presented as items on shopping lists (the "Monday"
and "Tuesday" lists) in an attempt to make the task more relevant to the individual.
After a delay of around twenty minutes during which unrelated testing occurs, free
recall, cued recall and recognition of the first list is assessed. This allows
assessment of such variables as levels of total recall and recognition on all trials,
learning rate across trials, consistency of item recall across trials, retention of
information over short and longer delays and enhancement of recall performance
by category cueing and recognition testing. The ability to learn and retain verbal
information is disrupted in a wide range of psychiatric disorders. This underscores
the importance of learning and memory assessment in any neuropsychological
evaluation. Learning and memory tests have been criticised (see Lezak 1995)
mainly because they involve calculating memory performance on the basis of a
single score made up of the total amount of material learned. However, as the
authors of this test point out, patients with memory impairment differ amongst
themselves on factors like encoding strategies, learning rates, consistency of recall,
degree of vulnerability to interference, retention of information over time, error
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types and improvement with cued and recognition testing. It is argued that other
existing assessments of verbal learning and memory have not addressed this
complexity.
The basic format of the CVLT was modelled on the Rey Auditory Verbal Learning
Test. Rey's test involved five presentations of a list of fifteen unrelated words, one
presentation of a new list of fifteen unrelated words and recall and recognition
testing of the first list. The CVLT, however, entails the learning of categorised
words instead of unrelated ones. The presentation of the words ensures that a
given word is never followed by one from the same category. Consecutive recall
of words from the same category, known as semantic clustering (Bousfield 1953)
reflects the extent to which the participant has actively imposed an organisation on
the list based on shared semantic features. This learning strategy typically results
in the most effective encoding into long-term memory. The CVLT word lists were
constructed to include high frequency well-established categories such as
"clothing" to avoid floor effects in brain-damaged patients; and also lower
frequency categories such as "spices and herbs" to minimise ceiling effects in
normal controls. The most common alternative strategy to semantic clustering is
serial-order clustering. This is the recall of items in the order in which they were
presented. Generally, serial-order clustering is a less effective learning strategy
than semantic clustering and according to Delis et al. (1987) it correlates with poor
performance on many other of the CVLT parameters.
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7.4.2.3.2 The Doors and People Test
Deficits in learning and memory are common and disabling in psychiatric illness.
These deficits, whether transitory or long-term, can be devastating as they impact
on everyday life and also can affect the capacity to benefit from therapy. The
Doors and People Test (Baddeley et al. 1994) offers a broad estimate of both visual
and verbal memory, combined with scores of learning and forgetting, recall and
recognition. The Doors and People test is useful in that it provides comparable
measures for visual and verbal memory whilst avoiding floor and ceiling effects
and including checks that deficits are not due to perceptual as opposed to
mnemonic problems, and also that measures are based on two sets of observations
to ensure reliable conclusions whilst also being relatively unstressful. The existing
tools measuring visual long-term memory all had certain drawbacks. The Rey
Osterreith figure has been widely used but gives a single measure based on a single
complex pattern which involves great perceptual and copying skills as well as
memory. The Weschler Memory Scale-Revised includes visual subtests but the
authors of the current test feel that they may encourage verbal encoding.
The test is made up of four separate subtests:
The Doors test is a test of visual recognition. The stimuli are coloured photographs
of doors from different types of buildings. Participants are presented with a target
sequence of twelve doors presented individually. This is then followed by the
recognition set in which the target doors are presented in 2x2 matrices with three
distracters, the participant being required to pick out the door he has previously
seen. The targets are presented in a random order and tested in a different order.
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Visual recall is tested by the Shapes test. Participants are shown four different line
drawings of crosses which they are asked to copy (to allow for the possibility that
distortions may be due to difficulty in drawing rather than memory). The original
crosses and the copy are then removed and participants asked to draw them again
from memory. The drawings are rated on three dimensions; overall shape
(elongated or square); presence of features at the ends of the arms and presence of
a feature at the intersection of the arms. This is repeated after a short delay to give
an indication of forgetting.
The Names test assesses verbal recognition. The target stimuli are twelve
forename/surname pairs which are presented singly, followed by the recognition
set consisting of the target items presented in vertical lists with three distracters, all
of which share the same forename. Names are a good choice of stimulus for a
general estimate of verbal memory as they are ecologically meaningful but do not
really allow for encoding in terms of meaning or visualisation as standard,
unrelated items do. Pilot studies were run to eliminate names associated with well-
known persons or companies. Again, presentation was randomised.
The People test assesses verbal recall. Participants are presented with colour
photographs of four people with a name and job written underneath. The
photographs are removed and participants then asked what, for example, the
doctor's name is. Participants are also asked to recall the four names after a short
delay.
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Performance norms for the Doors and People test were collected from a stratified
sample of 238 subjects with roughly equal numbers from each of the social class
categories and balanced for equal numbers of men and women from each of five
age bands ranging from 16 to 97. During development of the test, the authors
showed that it has a wide range of applicability and is sensitive to the effects of
Alzheimer's disease, stroke, normal ageing and schizophrenia. The test gives a
robust and sensitive overall memory score. The development process also showed
that the detailed pattern of performance varies from one patient group to another in
ways which suggest that different aetiologies produce different patterns of
impairment. However, due to lack of replication to date, the authors emphasise the
overall score as the most robust feature of the test.
7.4.2.4 Executive Function
7.4.2.4.1 The Hayling Sentence Completion Test
The Hayling Sentence Completion Test (Burgess and Shallice 1997) assesses
abilities associated with frontal lobe dysfunction and dysexecutive symptoms in
everyday life. It consists of two sections, providing a measure of basic task
initiation speed as well as performance on a response suppression task. Each
section consists of fifteen sentences which each have the last word missing. The
sentences are read aloud by the examiner to the participant who is then required to
make a verbal response. In section one, they are asked to complete the sentence
sensibly as quickly as possible, for example "he posted a letter without a...stamp".
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In section two the participant is required to give a word which is unconnected to
the sentences in every way, for example "the captain wanted to stay with the
sinking...banana". Section one measures simple response initiation through the
sum of response latencies, while section two gives two measures of response
suppression (error score and time taken to respond). Errors on section two are
words which straightforwardly complete the sentence or are closely semantically
related. Comparison of the error score and the time taken to respond in section two
may allow for some judgements to be made about the style of failure - for example
an impulsive individual may be quick to respond but make errors, but someone
who has difficulty disengaging from the expected response but can suppress it may
show the opposite pattern.
Four groups of subjects were used as an initial standardisation sample for the
Hayling test. One of the groups was made up of healthy volunteers and who were
drawn from a wide variety of educational backgrounds. The other three groups
were made up of neurological lesion patients who fell into three ultimate
categories. They were classified according to site of lesion based on a radiologist's
report of a CT scan. Any patient who had involvement of the frontal lobes was
classified as 'anterior'. Patients with lesions elsewhere in the cortex not involving
the frontal lobes were classified as 'posterior'. Patients with bilateral frontal lobe
lesions with no posterior involvement were considered as a separate 'bifrontal'
group. In a comparison of lesion and control groups' performance no laterality
effects were found on any measure of the Hayling test. The unilateral anterior
group were significantly poorer than controls on all measures. The posterior group
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however were not significantly poorer than controls on any of the Hayling test
measures.
7.4.2.4.2 The Brixton Spatial Anticipation Test
The Brixton Spatial Anticipation Test (Burgess and Shallice 1997) is a rule
attainment task similar to the Wisconsin Card Sort Test and again measures deficits
in frontal lobe function. It consists of a stimulus book in which each page shows
the same array of ten circles in two rows of five. Each circle is numbered from one
to ten. On each page, one of the circles is filled in blue. The position of the
coloured circle differs from page to page on most presentations. The participant is
shown one page at a time and asked to indicate where the next coloured circle will
be by trying to see a pattern or rule based on what they have seen on the previous
pages. This then assesses cognitive flexibility and rule detection and following.
There are three broad classes of error on this task: repeating one's response;
misapplication of a strategy; or 'guessing' or 'bizarre response'. These latter errors
are most likely in frontal lobe dysfunction. The Brixton test is designed to be a
straightforward test which is more pleasant and quicker for the volunteer to
perform than some others and which is quick to score and interpret.
The Brixton test was standardised in a similar fashion to the Hayling test described
above. The unilateral anterior group were significantly poorer than the posteriors
or the controls, with the posterior group not differing significantly from the
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controls. The bifrontal group were the poorest of all, but the contrast with the
unilateral anteriors just failed to reach significance.
Correlations between the two executive function tasks show significant
relationships between all the Hayling measures and the Brixton test. However, the
authors performed partial correlations removing the effects of age and IQ and
found that the resultant correlations were not significantly different from zero.
They therefore contend that the correlations between the two tests probably reflect
shared IQ and age effects rather than suggesting a common executive resource for
each test. Indeed, Burgess and Shallice (1997) reported individual cases with
frontal lobe lesions who showed double dissociations on the Hayling and Brixton
tests. These findings therefore suggest that the Hayling and Brixton tests probably
measure different cognitive processes or resources.
7.4.2.4.3 Verbal Fluency
In Verbal Fluency (Benton and Hamsher 1978) letter, participants are required to
say as many words as they can think of beginning with a given letter of the
alphabet (in this case, F, A and then S) excluding proper nouns and numbers over a
one minute trial. In the category or semantic condition, they are required to
generate as many words as they can which fit into a certain category (here,
animals, fruits and flowers). The score is the sum of acceptable words over the
trials. This measures a combination of efficiency of semantic processing (search
strategies) and integrity of semantic store (organisation of semantic memory) and
123
could therefore be described as measuring both executive function and memory.
Lezak (1995) states that word fluency provides an excellent means of finding out
how well and whether subjects organise their thinking. Fluency tests requiring
word generation according to an initial letter give the greatest scope to subjects
seeking a strategy for guiding the search for words and are most difficult for
subjects who cannot develop strategies of their own. Fluency tests calling for
items in a category provide the structure which is lacking in tests of initial letter
word generation. Lezak (1995) states that in the category test, those subjects with
good strategies develop sub-categories, for example in the category 'animals', they
produce clusters of wild animals, farm animals and so on. Other types of
clustering which have been observed include 'conceptual clustering', phonological
clustering such as 'salute', 'salvage'; 'baboon', 'beaver' and semantic clusters
which can be associated, such as 'soldier', 'salute', or shared ('salt', 'sugar').
Impaired verbal fluency is associated with frontal lobe damage producing cognitive
inflexibility. It may be that differences in the hierarchical organisation of the two
categories (letters and categories) may account for performance differences, as
retrieval by letter requires exploration of more category subsets than does retrieval




All participants were asked to attempt the same test battery. The participant was
seated in a comfortable situation with a table at hand to place materials on. The
purpose of the study was explained to participants and a brief history was taken.
Participants then undertook the neuropsychological test battery. Most of the
assessments included in the battery are self-paced so the time taken to complete
them varied. However, administration of the tests generally took around an hour
and a half.
Participants initially undertook the short form of the WAIS-R. The subtests were
completed in the following order: block design; similarities; object completion and
comprehension. This was then followed by the NART, then the CVLT. During
the interval before long-delay memory testing on the CVLT the Hayling and
Brixton tests were administered. Following completion of the CVLT participants
then attempted Verbal Fluency letter and category. The Doors and People test
concluded the neuropsychological test battery. The order of the tests was fixed in
order that any decline in motivation or fatigue could be controlled for. The
majority of tests required verbal responses. The tester recorded all the participant's
responses. Following the completion of the neuropsychological test battery, the
symptom severity rating scales were filled out. The SADS-L was subsequently
completed using the patient's case notes.
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Not all patients were able to complete testing in one session. If this was the case,
the patient was seen again as soon as possible to finish the battery. However, not
all patients did undertake all the assessments due to refusal or time constraints.




The control group comprised 31 healthy controls and 6 married-in non-ill members
of Family 22. The unipolar affective disorder group (UPs) consisted of 41
depressed participants and the bipolar affective disorder group (BPs) was made up
of 37 patients. Twenty-six patients made up the schizophrenic group. The Family
22 group comprised fifteen members of the family carrying the haplotype, seven of
whom were unaffected by psychiatric illness and eight of whom had a diagnosis of
either recurrent unipolar or bipolar affective disorder.
8.2 Demographic data for all groups
Table 1 shows the results of all the groups (controls, unipolar depressed patients,
bipolar disorder patients, schizophrenic patients and Family 22 haplotype carriers)
for age, IQ and sex. For continuous variables, groups were compared by one way
analysis of variance (ANOVA) and for dichotomous traits (sex) by chi-square. No
significant differences were apparent on age, sex, estimated premorbid intelligence
level and current intelligence level (measured by NART and WAIS-R










































































8.3 Performance of control and patient groups on cognitive tests
Between group differences in the cognitive tests were assessed using one way
analysis of variance. The significance of differences between means were further
examined with Scheffe tests. Where the data were not normally distributed a
Kruskall-Wallis non-parametric one-way analysis of variance was conducted with
significant results further examined with Mann-Whitney tests. Tables 2 to 10 show
the means and standard deviations of the performance of the control, unipolar
disorder, bipolar disorder and schizophrenic groups and the comparisons between
the means using Scheffe. For Mann-Whitney comparisons the mean and range are
presented.
Distribution of data was examined using Kormolgorov-Smirnoff tests of normality.
The following test results did not conform to normal distribution and were
analysed by non-parametric tests: Hayling Sentence Completion Test (FISCT) time
taken to complete sensible completion; HSCT time taken to complete unconnected
completion; HSCT time taken for unconnected completion less time taken for
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Table 4 Mann-Whitney comparisons ofHayling Sentence Completion Test
(HSCT) Time to Complete Sensible Completion showing means (range)

























Table 5 Mann-Whitney comparisons of Hayling Sentence Completion Test
(HSCT) Time to Complete Unconnected Completion showing means (range)

























Table 6 Mann-Whitney comparisons ofHayling Sentence Completion Test
(HSCT) Time to Complete Unconnected Completion less time taken to complete
sensible completion showing means (range)

























Table 7 Mann-Whitney comparisons of number of Type A errors made in HSCT
unconnected completion showing means (range)


























Table 8 Mann-Whitney comparisons of number of Type B errors made in HSCT
unconnected completion showing means (range)


























Table 9 ANOVA showing groups' performances on the Brixton Spatial
Anticipation Test showing means (standard deviations)
Controls Unipolars Bipolars Schizophrenics F Scheffe





















































































Table 11 Summary of results where patient groups differ from controls showing
Scheffe p values
Cognitive Measure Unipolars Bipolars Schizophrenics
CVLT 1 - P=0.005 P=0.000
CVLT 1-5 - P=0.02 P=0.000
CVLT SD - P=0.01 P=0.000
CVLT LD - P=0.01 P=0.005
CVLT Rec - - P=0.03
CVLT Rec less FP - - -
D&P People - - -
D&P Doors - P=0.008 P=0.008
D&P Shapes - - -
D&P Names - P=0.01 -
D&P Total Age Scale - P-0.04 -
D&P VisVerb - - -
D&P RecallRec - - -
D&P Forget - - -
HSCT Time 1 P-0.003 P=0.000 -
HSCT Time 2 - P=0.001 P-0.008
HSCT Time 2 less 1 - - -
HSCT Type A Errors - - -
HSCT Type B Errors - - -
Brixton Raw - - P=0.001
Brixton Scale - - P=0.008
VF Letters - - -
VF Categories - P=0.03 P=0.03
VF All - P=0.02 P=0.03
These results show that the bipolar and schizophrenic group are similar in their
cognitive deficits but that the schizophrenic group is more impaired in executive
function tasks. The relative normality of the unipolar group should also be noted.
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8.4 Multiple Testing
A large number of comparisons are being made and some apparently significant
differences between groups could arise by chance. This can be addressed in two
ways:
1. Applying a Bonferroni Correction (Miller 1981). If a null hypothesis
which is in fact true is tested taking 0.05 as the critical significance level,
there is a probability of 0.95 of coming to a 'not significant' (correct)
conclusion. If twenty such hypotheses are tested, the expected number of
spurious significant results is 20x0.05=1. If the alpha level is made small
enough, the probability that none of the separate tests is significant can be
made equal to 0.95. This means that if any of the comparisons has a p
value less than alpha, the difference is significant at the 0.05 level. If the
alpha level is divided by n, where alpha = 0.05 and n = the number of
comparisons, which in this instance is 72, this would mean taking a p level
of 0.0007 to be significant at the 0.05 level. This is conservative and may
lead to rejection of real findings because it could be argued that for some
tests there are apriori reasons for expecting a change.
2. Only considering results to be significant at the p=0.01 level or less, as
there are 72 comparisons so at the 0.05 level one would expect less than
four spuriously significant results, whereas at the 0.01 level, less than one
spurious result would be expected. This was the approach taken.
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8.5 Effect of symptom severity on cognitive performance in the
patient groups
All the patient groups were assessed on the severity of their symptoms with
diagnosis-specific rating scales. In order to assess whether their clinical state at the
time of testing was adversely affecting their cognitive performance, performance
on cognitive test was correlated with scores on the severity rating scales.
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The unipolar disorder group was assessed using the Hamilton Depression Rating
Scale (mean 14.2, SD 6.9) and the Beck Depression Inventory (mean 25.7, SD
10.7). Correlations between these scales and key cognitive measures are presented
in Tables 12 and 13.
Table 12 Correlational Analyses for symptom severity and cognitive performance
Unipolar Group
Hamilton Score
Neuropsychological Test Score Spearman's rs (p value)
CVLT 1 0.127 (0.448)
CVLT 1-5 0.108 (0.578)
CVLT Long Delay 0.172 (0.303)
CVLT Total Recognition less False Positives 0.138 (0.409)
HSCT Time 1 0.001 (0.996)
HSCT Time 2 -0.016 (0.923)
HSCT Time 2 less 1 0.012 (0.945)
Brixton Scale Score 0.014 (0.937)
Verbal Fluency Total Score -0.168 (0.319)
Doors and People Total Age Scale Score 0.156 (0.447)
Table 13 Correlational Analyses for symptom severity and cognitive performance
Unipolar Group
Beck Score
Neuropsychological Test Score Spearman's rs (p value)
CVLT 1 0.143 (0.420)
CVLT 1-5 0.145 (0.412)
CVLT Total Recognition less False Positives 0.021 (0.906)
HSCT Time 1 -0.534 (0.001)**
HSCT Time 2 -0.299 (0.086)
HSCT Time 2 less 1 -0.387 (0.044)
Brixton Scale Score 0.299 (0.091)
Verbal Fluency Total Score 0.020 (0.911)
Doors and People Total Age Scale Score 0.172 (0.433)
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The bipolar disorder group were assessed on the same depression rating measures
(HDRS mean 5.6, SD 7.1; BDI mean 12.9, SD 12.2) and also on the Modified
Manic Rating Scale (mean 1.7, SD 3.8). Correlations between these scales and key
cognitive measures are presented in Tables 14 and 15.
Table 14 Correlational Analyses for symptom severity and cognitive performance
Bipolar Group
Hamilton Score
Neuropsychological Test Score Spearman's rs (p value)
CVLT 1 0.051 (0.776)
CVLT 1-5 0.045 (0.805)
CVLT Long Delay 0.104 (0.577)
CVLT Total Recognition less False Positives 0.121 (0.517)
HSCT Time 1 0.144 (0.433)
HSCT Time 2 -0.208 (0.262)
HSCT Time 2 less 1 -0.284 (0.121)
Brixton Scale Score 0.130 (0.494)
Verbal Fluency Total Score -0.042 (0.829)
Doors and People Total Age Scale Score -.0083 (0.698)
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Table 15 Correlational Analyses for symptom severity and cognitive performance
Bipolar Group
Beck Score
Neuropsychological Test Score Spearman's rs (p value)
CVLT 1 0.090 (0.625)
CVLT 1-5 -0.148 (0.418)
CVLT Total Recognition less False Positives -0.055 (0.773)
HSCT Time 1 -0.016 (0.933)
HSCT Time 2 -0.159 (0.402)
HSCT Time 2 less 1 -0.213 (0.258)
Brixton Scale Score 0.085 (0.655)
Verbal Fluency Total Score -0.202 (0.313)
Doors and People Total Age Scale Score -0.230 (0.292)
MMRS Score
Neuropsychological Test Score Spearman's rs (p value)
CVLT 1 -0.224 (0.189)
CVLT 1-5 -0.277 (0.102)
CVLT Long Delay -0.042 (0.812)
CVLT Total Recognition less False Positives -0.034 (0.848)
HSCT Time 1 0.220 (0.207)
HSCT Time 2 0.127 (0.475)
HSCT Time 2 less 1 0.115 (0.518)
Brixton Scale Score -0.197 (0.454)
Verbal Fluency Total Score -0.035 (0.854)
Doors and People Total Age Scale Score -0.071 (0.734)
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The schizophrenic group's symptom severity was measured with the Brief
Psychiatric Rating Scale (mean 6.5, SD 3.7). Correlations between this scale and
key cognitive measures are presented in Table 16.
Table 16 Correlational Analyses for symptom severity and cognitive performance
Schizophrenic Group
BPRS Score
Neuropsychological Test Score Spearman's rs (p value)
CVLT 1 0.081 (0.687)
CVLT 1-5 -0.130 (0.526)
CVLT Total Recognition less False Positives -0.182 (0.384)
HSCT Time 1 0.024 (0.913)
HSCT Time 2 -0.112 (0.601)
HSCT Time 2 less 1 -0.053 (0.807)
Brixton Scale Score 0.033 (0.874)
Verbal Fluency Total Score -0.198 (0.390)
Doors and People Total Age Scale Score -0.122 (0.754)
Scores on the cognitive tests did not correlate significantly with symptom severity
measures in any of the patient groups.
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8.6 Performance of Family 22 "high risk" on cognitive tests
compared with the control group
Analysis of the family data was hypothesis-driven. The hypotheses were that both
affected and unaffected haplotype carriers would be similar to the bipolar patient
group on the cognitive measures. Family 22 has a high incidence of bipolar and
unipolar affective disorder. Therefore the Family 22 haplotype carriers (the "high
risk" group) were compared with the control group on only those tests where
between group differences had been observed for the bipolar disorder group. The
F22 family members not at risk were included in the control group for this analysis
after establishing the equivalence of their performances. Group differences were
examined with Mann-Whitney U tests and independent t tests. Means and ranges
are presented in Tables 17 to 20.
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Table 17 Comparisons of controls' and Family 22 family members' performances




























185.0 0.08 1.83 0.08
Table 18 Mann-Whitney comparisons of controls' and Family 22 family members'

























48.0 0.02 3.07 0.004
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Table 19 Mann-Whitney comparisons of controls' and Family 22 members'
performances on Hayling Sentence Completion Test (HSCT) time to complete




















Table 20 Mann-Whitney comparisons of controls' and Family 22 members'




















146.0 0.01 3.14 0.004
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8.7 Comparison of affected and unaffected Family 22 "high risk"
group's cognitive performance with controls
The Family 22 group was partitioned into unaffected and affected groups and their
scores on key cognitive measured were analysed in relation to the control group.
The results of the Mann-Whitney comparisons with means and range are presented
in Tables 21 to 28
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Table 21 Mann-Whitney comparisons of unaffected and affected haplotype carrier




































































6.0 0.33 0.58 0.58
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Table 22 Mann-Whitney comparisons of controls and unaffected Family 22































































20.0 0.17 -1.77 0.09
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Table 23 Mann-Whitney comparisons of controls and affected Family 22 haplotype































































17.0 0.04 2.92 0.008
No significant differences were found between the affected and unaffected F22 "at
risk" group on any of the key cognitive measures. When comparisons were made
between the control group and the unaffected F22 group, number of words recalled
on CVLT trial 1 showed a trend towards significance between the groups and there
was also a significant difference in the total number of words generated in Verbal
Fluency.
In comparisons between the control group and the affected F22 group, several
significant differences were found, namely CVLT trial 1 and trials 1 to 5. There
was a trend towards significance on the HSCT sensible completion and a
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significant difference on the unconnected completion. A further trend was noted in
the Verbal Fluency total, and the F22 affected group's Doors and People total age
scale score was significantly lower than the control group.
8.8 Effect of symptom severity on cognitive performance in
Family 22 haplotype carriers
The Family 22 haplotype carriers were assessed on the severity of their symptoms,
if any, with depression and mania rating scales. In order to assess whether their
state at the time of testing was adversely affecting their cognitive performance,
performance on cognitive test was correlated with scores on the severity rating
scales.
The Family 22 group's mean score on the HDRS was 4.1 (SD 5.6), 5.8 (SD 7.3) on
the BDI and 0.3 (SD 0.8) on the MMRS. Correlations between these scales and key
cognitive measures are presented in Table 24.
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Table 24 Correlational analyses for symptom severity and cognitive performance
Family 22 haplotype carrier group
Hamilton Score
Neuropsychological Test Score Spearman's rs (p value)
CVLT 1 0.051 (0.776)
CVLT 1-5 0.045 (0.805)
CVLT Long Delay 0.104 (0.577)
CVLT Total Recognition less False Positives 0.121 (0.517)
HSCT Time 1 0.144 (0.433)
HSCT Time 2 -0.208 (0.260)
HSCT Time 2 less 1 -0.284 (0.121)
Brixton Scale Score 0.130 (0.494)
Verbal Fluency Total Score -0.042 (0.829)
Doors and People Total Age Scale Score -0.083 (0.698)
Beck Score
Neuropsychological Test Score Spearman's rs (p value)
CVLT 1 -0.498 (0.119)
CVLT 1-5 -.592 (0.055)
CVLT Total Recognition less False Positives -0.202 (0.551)
HSCT Time 1 0.248 (0.462)
HSCT Time 2 0.418 (0.200)
HSCT Time 2 less 1 0.414 (0.206)
Brixton Scale Score -0.466 (0.148)
Verbal Fluency Total Score -0.300 (0.371)
Doors and People Total Age Scale Score -0.214 (0.645)
MMRS Score
Neuropsychological Test Score Spearman's rs (p value)
CVLT 1 -0.244 (0.189)
CVLT 1-5 -0.277 (0.102)
CVLT Long Delay -0.042 (0.812)
CVLT Total Recognition less False Positives -0.034 (0.848)
HSCT Time 1 0.220 (0.204)
HSCT Time 2 0.127 (0.475)
HSCT Time 2 less 1 0.115 (0.518)
Brixton Scale Score -0.135 (0.454)
Verbal Fluency Total Score -0.035 (0.884)
Doors and People Total Age Scale Score 0.071 (0.734)
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Scores on the cognitive tests did not correlate significantly with symptom severity
measures in this group.
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8.9 Effects of sex on cognitive performance in patient groups and
Family 22 haplotype carriers
Sex differences within the groups on key cognitive measures were examined with
Mann-Whitney tests. The results are presented in Tables 25 to 28.
Table 25 Mann-Whitney comparisons of males versus females in the unipolar
disorder group on key cognitive measures showing means (standard deviations)



























































Table 26 Mann-Whitney comparisons of males versus females in the bipolar
disorder group on key cognitive measures showing means (standard deviations)



























































Table 27 Mann-Whitney comparisons ofmales versus females in the schizophrenic
group on key cognitive measures showing means (standard deviations)



























































Table 28 Mann-Whitney comparisons ofmales versus females in the Family 22
haplotype carrier group on key cognitive measures showing means (standard
deviations)


























































No significant effects of sex were found within any of the groups.
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8.10 Effects of medication on cognitive performance in the patient
and Family 22 haplotype carrier group
The numbers of patients taking medication at the time of testing are listed in
Appendix 1 along with the type ofmedication.
Within the bipolar disorder group, the effects of lithium on cognitive performance
was examined by comparing the performance of patients taking lithium with those
patients not on the drug with Mann-Whitney tests. The results are presented in
Table 29.
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Table 29 Mann-Whitney comparisons of cognitive performance in bipolar disorder
patients taking lithium with those not taking lithium showing means (standard
deviations)


























































No significant differences were found between bipolar disorder patients taking
lithium and those not in any of the key cognitive measures.
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8.11 Effect of age of onset of illness on cognitive performance in
patient groups and Family 22 haplotype carriers
Correlational analyses on age of onset effects within the groups on key cognitive
measures were carried out. The results are presented in Tables 30 to 33.
Table 30 Correlational analyses of age of onset and key cognitive measures
unipolar disorder group
Neuropsychological Test Score Spearman's rs (p value)
CVLT 1 -0.499 (0.002)*
CVLT 1-5 -0.448 (0.007)*
CVLT Total Recognition less False Positives -0.498 (0.002)*
HSCT Time 1 0.141 (0.428)
HSCT Time 2 -0.146 (0.411)
HSCT Time 2 less 1 -0.209 (0.236)
Brixton Scale Score -0.354 (0.043)
Verbal Fluency Total Score -0.405 (0.019)
Doors and People Total Age Scale Score -0.236 (0.267)
*.Correlation is significant at the 0.01 level
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Table 31 Correlational analyses of age of onset and key cognitive measures
bipolar disorder group
Neuropsychological Test Score Spearman's rs (p value)
CVLT 1 0.029 (0.892)
CVLT 1-5 0.213 (0.307)
CVLT Total Recognition less False Positives -0.034 (0.873)
HSCT Time 1 -0.123 (0.557)
HSCT Time 2 -0.084 (0.689)
HSCT Time 2 less 1 -0.097 (0.645)
Brixton Scale Score 0.105 (0.617)
Verbal Fluency Total Score 0.104 (0.637)
Doors and People Total Age Scale Score -0.291 (0.200)
Table 32 Correlational analyses of age of onset and key cognitive measures
schizophrenic group
Neuropsychological Test Score Spearman's rs (p value)
CVLT 1 0.667 (0.219)
CVLT 1-5 0.900 (0.037)
CVLT Total Recognition less False Positives 0.400 (0.600)
HSCT Time 1 -0.700 (0.188)
HSCT Time 2 0.600 (0.285)
HSCT Time 2 less 1 0.600 (0.285)
Brixton Scale Score 0.100 (0.873)
Verbal Fluency Total Score -0.400 (0.600)
Doors and People Total Age Scale Score -1.000 (1.000)
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Table 33 Correlational analyses of age of onset and key cognitive measures
Family 22 haplotype carriers
Neuropsychological Test Score Spearman's rs (p value)
CVLT 1 -0.266 (0.525)
CVLT 1-5 -0.036 (0.933)
CVLT Total Recognition less False Positives -0.797 (0.018)
HSCT Time 1 0.407 (0.317)
HSCT Time 2 -0.228 (0.588)
HSCT Time 2 less 1 -0.252 (0.548)
Brixton Scale Score -0.428 (0.290)
Verbal Fluency Total Score -0.180 (0.670)
Doors and People Total Age Scale Score 0.154 (0.805)
There were significant negative correlations in the unipolar disorder group between
age of onset of illness and the CVLT measures number of words recalled in trial 1
and trials 1 to 5, and total number of words recognised less the number of false
positives.
There were no significant correlations between age of onset and key cognitive
measures in any of the other groups.
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8.12 Effect of duration of illness on cognitive performance in
patient groups and Family 22 haplotype carriers
Correlational analyses on duration of illness effects within the groups on key
cognitive measures were carried out. The results are presented in Tables 34 to 37.
Table 34 Correlational analyses of duration of illness and key cognitive measures
unipolar disorder group
Neuropsychological Test Score Spearman's rs (p value)
CVLT 1 -0.35 (0.04)*
CVLT 1-5 -0.24 (0.17)
CVLT Total Recognition less False Positives -0.29 (0.09)
HSCT Time 1 0.15 (0.40)
HSCT Time 2 0.41 (0.02)
HSCT Time 2 less 1 0.47 (0.005)**
Brixton Scale Score -0.29 (0.09)
Verbal Fluency Total Score -0.09 (0.62)
Doors and People Total Age Scale Score -0.08 (0.70)
*.Correlation is significant at the 0.05 level **.Correlation is significant at the
0.01 level
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Table 35 Correlational analyses of duration of illness and key cognitive measures
bipolar disorder group
Neuropsychological Test Score Spearman's rs (p value)
CVLT 1 -0.24 (0.25)
CVLT 1-5 -0.03 (0.89)
CVLT Total Recognition less False Positives -0.14 (0.53)
HSCT Time 1 0.17 (0.43)
HSCT Time 2 -0.03 (0.88)
HSCT Time 2 less 1 -0.06 (0.78)
Brixton Scale Score -0.58 (0.002)**
Verbal Fluency Total Score -0.20 (0.36)
Doors and People Total Age Scale Score -0.17 (0.47)
**.Correlation is significant at the 0.01 level
Table 36 Correlational analyses of duration of illness and key cognitive measures
schizophrenia group
Neuropsychological Test Score Spearman's rs (p value)
CVLT 1 -0.15 (0.81)
CVLT 1-5 -0.60 (0.29)
CVLT Total Recognition less False Positives -0.40 (0.60)
HSCT Time 1 0.20 (0.75)
HSCT Time 2 -0.90 (0.04)*
HSCT Time 2 less 1 -0.90 (0.04)*
Brixton Scale Score -0.10 (0.87)
Verbal Fluency Total Score -0.20 (0.80)
Doors and People Total Age Scale Score 1.00 **
*.Correlation is significant at the 0.05 level **.Correlation is significant at the
0.01 level
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Table 37 Correlational analyses of duration of illness and key cognitive measures
Family 22 haplotype carriers
Neuropsychological Test Score Spearman's rs (p value)
CVLT 1 0.01 (0.98)
CVLT 1-5 -0.67 (0.07)
CVLT Total Recognition less False Positives 0.06 (0.88)
HSCT Time 1 0.69 (0.06)
HSCT Time 2 0.02 (0.96)
HSCT Time 2 less 1 0.14 (0.74)
Brixton Scale Score 0.08 (0.84)
Verbal Fluency Total Score -0.48 (0.23)
Doors and People Total Age Scale Score 0.20 (0.75)
There were significant positive correlations in the unipolar disorder group between
duration of illness and HSCT time for unconnected completion and unconnected
completion less time for sensible completion. A significant negative correlation
was found between duration of illness and CVLT number of words recalled in trial
1.
A significant negative correlation between duration of illness and Brixton scale
score was found in the bipolar disorder group.
Significant negative correlations between duration of illness and HSCT time for
unconnected completion and unconnected completion less time for sensible
completion were shown in the schizophrenia group.
No significant correlations were found between duration of illness and key
cognitive measures in the F22 "at risk" group, perhaps due to size limitations.
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9.0 DISCUSSION
9.1 Summary of main findings
This study has shown that patients with schizophrenia and bipolar disorder have
impaired performance in several domains of cognitive function and the unipolar
depressed patients show no differences from controls. These results confirm and
extend the findings of a number of published studies. The second major finding
from this work is that cognitive deficits were measured in relatives in one family,
who were at high genetic risk of developing bipolar disorder but who had not
developed symptoms of the disorder. It can be concluded that these cognitive
deficits associated with increased genetic risk may be considered as
'endophenotypes' in genetic studies of bipolar disorder.
The bipolar affective disorder group were impaired relative to controls on several
measures of verbal learning and memory, namely California Verbal Learning Test
immediate recall condition (CVLT trial 1), a global measure of learning
performance (CVLT total score of immediate free recall trials 1 to 5), and short
and long delay free recall. The bipolar group was also impaired compared to
controls on measures of visual and verbal recognition (Doors and People subtests
Doors and Names), reflected in their overall lower total age scale score on the
Doors and People test. On executive function tasks, the bipolar group was slower
to complete both the sensible and unconnected completion trials of the Hayling
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Sentence Completion Test. The Verbal Fluency task of generating words fitting
into particular categories was performed more poorly by the bipolar group than by
controls, and the bipolar group generated fewer words overall in Verbal Fluency
than controls.
The schizophrenic group's performance on the cognitive tests was similar to that of
the bipolar group in general profile. The schizophrenic group differed from
controls on all the measures of verbal learning and memory mentioned above, with
the addition of impaired delayed recognition. The schizophrenic group was also
impaired relative to controls on a measure of visual recognition (Doors and People
subtest Doors). The schizophrenia group differed from the bipolar group in the
degree of impairment and in tests of executive function, being slower to complete
the unconnected trial of the Hayling Sentence Completion Test. This group also
exhibited deficits on the Brixton Spatial Anticipation Test, making significantly
more errors than the control group. The schizophrenic group's performance on
measures of Verbal Fluency was equivalent to that of the bipolar affective disorder
group and impaired relative to the control group.
The unipolar affective disorder group was relatively unimpaired when compared to
the normal control group. The only significant difference between this group and
the controls was in the time taken to complete the sensible completion trial of the
Flayling Sentence Completion Test, a measure of basic initiation speed.
166
In the three patient groups, schizophrenic, bipolar and unipolar affective disorder,
cognitive impairment was not related to severity of symptoms or medication at the
time of testing, so cognitive impairments appear to be measures of 'trait' rather
than 'state'.
These results show that bipolar affective disorder patients not experiencing an
acute episode of illness are cognitively impaired when compared to healthy
controls and that the deficits they experience are generally similar to those found in
schizophrenic patients, the main difference between the bipolar and schizophrenic
groups being in executive ability.
Analysis of the data from members of the extended bipolar pedigree (Family 22)
showed that relatives with bipolar or unipolar disorder, in this family, had similar
cognitive changes to the unrelated bipolar patient group. Strikingly, a group of
relatives who had no symptoms of unipolar or bipolar disorder but who carried the
genetic markers associated with increased risk of bipolar disorder also had
significant cognitive deficits. The majority of tests that highlighted cognitive
changes in the bipolar group also showed significant differences or trends towards
significance in the Family 22 "high risk" group. No significant differences on
performance of the cognitive tests were found between those haplotype carriers
with a diagnosis of psychiatric illness and unaffected haplotype carriers.
Further investigation showed that cognitive changes noted in the patient and
Family 22 groups were not due to the effects ofmedication or symptom severity at
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the time of testing. Taken overall, these results show that these neuropsychological
tests are trait markers of risk in this bipolar/unipolar family.
9.2 Cognitive changes in schizophrenia
The impairments apparent in the schizophrenia group, in verbal learning and
memory and in executive function, support previous findings reported in the
schizophrenia literature. Memory dysfunction is a reliable finding in schizophrenia
(Levin et al. 1989), although there is some debate as to the nature of memory
impairment in the disorder. The finding in this study of impaired global verbal
learning performance across trials is suggestive of an acquisition deficit, although
it is not possible to conclude from these results what the mechanism for this deficit
may be, as difficulties with attention, encoding, motivation and organisation of the
to-be-remembered information have all been implicated (Paulsen et al. 1995).
However, as the schizophrenia group did not appear to exhibit rapid forgetting of
the acquired information after a delay period (as the short and long delay recall
performances are similar, although deficient compared to controls) this suggests
that this group do not suffer from particular storage deficits. The finding of poor
delayed verbal recognition when compared to controls suggests that there may be
some degree of retrieval deficit as the recognition format allows for the
demonstration of acquired knowledge without relying on the effortful initiation of
search and retrieval mechanisms. However, as there is no significant difference
between controls and the schizophrenia group on the measure of recognition
performance after the removal of false positives, this is suggestive more of an
168
encoding deficit and may reflect disorganisation of the information. The findings
generally are in line with the large-scale Heinrichs and Zakzanis (1998) meta¬
analysis of cognitive impairment in schizophrenia that identified impairment in
global verbal memory as the single most severe impairment. More specifically, the
findings support the study by Calev (1984) of chronic schizophrenic patients and
controls on recall and recognition tasks, finding both aspects of memory impaired
in the patient group. However, there was a significant impairment of visual
recognition compared to controls as evidenced by poor performance on the Doors
subtest of the Door and People task, the only subtest of this task that was impaired
in the schizophrenic group. This again is suggestive of encoding deficits, or may
simply reflect the increased difficulty of this recognition task as opposed to many
others, as it was deliberately designed to compensate for the problem that
recognition tasks are often easier than recall tasks, as photographs of doors were
presented, stimuli which are similar anyway, and then target doors required to be
recognised from three distracters in each case. However, as there was no
corresponding deficit in the verbal recognition task, requiring the recognition of
target names from three distracters, this may reflect a specific verbal recognition
deficit. Alternatively, it may be that as names are more 'everyday' stimuli, it may
be that patients are simply more practised in recognising them. These findings do
not support previous theories of an amnesic syndrome in schizophrenia proposed
by McKenna et al. (1990) because deficits would be found across modalities,
whereas these results are more suggestive of a verbal deficit. There has been some
controversy as to whether the memory deficits observed in schizophrenia are
primary cognitive deficits or are secondary to other deficits, for example in
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executive function. Current neuropsychological methodology is unable to tease
apart these domains as any neuropsychological instrument involves a variety of
cognitive resources. Goldberg et al. (1989) have suggested that the memory
impairment in schizophrenia appears to affect recall over recognition, possibly
indicative of an executive pattern of impairment with difficulties implementing
effective search and retrieval strategies. These results are in line with a recent
meta-analysis finding significant memory impairment largely for recall, but with
some evidence for impaired recognition memory, associated with hippocampal and
temporal lobe dysfunction, brain regions implicated in encoding and storage
(Aleman et al. 1999).
Executive function deficits were observed in this sample, notably on the Brixton
Spatial Anticipation Test and in Verbal Fluency. Deficits on the Brixton Test are
in line with other findings in schizophrenia including poor performance on other
'rule' attainment tasks such as the Wisconsin Card Sort Test. It has been suggested
that deficits on tasks such as these stem form an inability to 'abstract' or to grasp
essential features. This usually produces persistence in adhering to one rule and a
failure to shift responses from the previously irrelevant to the relevant, leading to
an inability to detect rules (Faglioni, 1999). This reflects reactive inflexibility, a
deficit in processing information gathered from the environment to discover rules
and change behaviour. Stuss et al. (1983) showed with this task that patients with
schizophrenia have difficulty attaining concepts and make incorrect perseverative
errors even when given feedback. More recently, Weickert (2000) found subtle
deficits in a similar task, the Wisconsin Card Sort Test, even in patients with
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preserved intellect, similar to the sample here who did not display reduced 1Q
scores relative to the control group. Executive function tasks such as these have
been associated with dysfunction in the frontal lobes, notably in reduced perfusion
in the dorso-lateral prefrontal cortex (Weinberger et al. 1988).
Goldberg et al. (1988) have also shown that schizophrenic patients exhibit poor
performance on tasks that measure guided lexical search such as Verbal Fluency.
Lezak (1995) has asserted that word generation according to letter is the more
difficult of the two conditions for subjects who have difficulty developing efficient
search strategies of their own. It is noteworthy, although difficult to explain, that
controls and schizophrenics did not differ on this task but on the allegedly less
demanding category condition. One possible explanation could be that the fluency
deficits in this group of schizophrenic patients are due to a disorganisation or
degradation of the semantic store, rather than retrieval dysfunction. If the deficit
were one of guided search or retrieval, the schizophrenia group would be expected
to demonstrate equal deficits on both letter (phonologic) and category (semantic)
tasks. However, if there is a problem with the semantic store, the category
condition which requires access to and search within a network would be more
impaired than phonologic search, which requires only phonemic or lexical cues to
guide word production. Gourovitch et al. (1996) investigated the nature of fluency
deficits in schizophrenia patients and found that although the schizophrenics were
impaired on both phonologic and semantic fluency compared to normal controls,
they demonstrated particular difficulty in the semantic category, producing the
opposite pattern of results to that of the control group who consistently generated
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more words in the category than the letter condition. They concluded that
schizophrenia may be associated with a breakdown of semantic information
processing beyond "executive" search and retrieval, and that this is suggestive of
dysfunction of the frontal and temporoparietal areas of the brain. These findings
are in line with those of the present study. As predicted, the schizophrenic group
generated fewer words in total than the control group which is also in agreement
with the Gourovitch et al. (1996) of impaired performance generally on this task.
This group of schizophrenia sufferers did not show impairment on the Hayling
Sentence Completion Test apart from a slower time to complete the unconnected
condition compared to controls. The lack of errors may be considered to be at odds
with errors on the Brixton task, as it could be considered that if executive function
generally is impaired, one may expect to see the most stereotyped or simplest
reactions in response to surface cues in the environment, regardless of whether
they are incorrect for the task at hand. However, these results suggest that the
inhibitory aspects of executive function may be relatively unimpaired in this group,
taking longer as they do to complete the more demanding condition but doing so
successfully. This would tend to agree with Crowe's (1998) assertion that
executive dysfunction in schizophrenia related more to the diminution of drive and
direction rather than disinhibition, consistent with a compromised dorso-lateral
prefrontal cortex. However, it may be that in this group of reasonably high-
functioning individuals, the task is simply not sufficiently sensitive to pick up on
dysfunctions of this type.
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Generally, the findings for this sample of schizophrenic patients tend to support the
findings of Buchsbaum (1990) of widespread neuropsychological dysfunction
rather than of Weinberger et al. (1986) who proposed more selective executive
function deficits. Neuropsychological tests are imperfect in localising deficits
neuroanatomically but the pattern of impairments found in this study support the
proposal of Gold et al (1992b) that neural systems associated with frontal and
temporal lobes in schizophrenia are compromised.
Performance on cognitive testing did not correlate with measures of symptom
severity, years of illness or medication, supporting previous findings of Goldberg
et al. (1993a) who found that treatment with neuroleptics led to improvement in
psychotic symptomatology without a corresponding improvement in cognitive
function. This would suggest that neuropsychological impairments are relatively
independent of psychotic symptoms and medication and are likely to be central and
enduring features of the disease process.
9.3 Cognitive changes in unipolar affective disorder
The performance of the unipolar disorder group was not significantly different to
that of the control group apart from a measure of basic initiation speed, Hayling
Sentence Completion Test sensible completion. This suggests a deficit in
psychomotor speed and is most likely to be a state-dependent deficit, correlating as
it does with the Beck Depression Inventory score. Although memory and
executive function deficits have been widely documented in unipolar affective
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disorder as highlighted by Austin et al. (2001), there is little evidence for persistent
deficits outwith periods of acute illness in unipolar depression, and what evidence
there is tends to suggest that persistent deficits are found more in elderly patients
with depression. Indeed Grant et al. (2001) concluded from a study investigating
cognitive impairment in a large sample of unmedicated, nonbipolar, nonchronic
younger adults that major depressive disorder in healthy younger outpatients does
not cause appreciable impairments in cognitive functioning, findings supported by
the present study.
Significant negative correlations between verbal memory and age of onset of
depression is somewhat unexpected, suggesting as it does that an earlier age of
onset produces better performance. This may be explained by the fact that much of
the unipolar affective disorder group was made up of young people, with early
onset but short duration of illness.
9.4 Cognitive changes in bipolar affective disorder
The findings of this study of persistent cognitive deficits in remitted bipolar
disorder support recent findings of impaired cognitive function in euthymic
patients who have recurrent bipolar affective disorder (Tham et al. 1998; van Gorp
1998; Ferrier et al. 1999). The bipolar group was significantly impaired on
measures of verbal learning and recall compared to controls, in keeping with a
study by Cavanagh et al. (2002) who reported deficits in immediate recall, global
verbal learning, and short and long delay recall in a case-control study of euthymic
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bipolar patients. These deficits were remarkably similar to those observed in the
schizophrenia sample in this study, suggesting an acquisition difficulty, but no
particular difficulties in storage of the to-be-remembered information, evidenced
by the equivalence of short and long delay recall scores, even though these were
poor compared to the controls' performance. Cavanagh et al. also found deficits in
verbal recognition on the California Verbal Learning Test and this was not found
in the present study. The performance on the recognition aspects of the California
Verbal Learning Test suggest that this group of bipolar patients may have deficits
in accessing the stored material, and perhaps in generating search and retrieval
strategies. However, deficits in verbal recognition were observed on the Doors and
People subtest Names, along with visual recognition as illustrated by deficits in the
Doors and People subtest Doors. The pattern of deficits observed in the memory
tasks in this study do not support older notions of a selective right hemisphere
dysfunction in bipolar disorder (Goodwin and Jamison 1990), as complex verbal
learning and memory functions are clearly impaired in this patient group. It may
be that the recognition tasks in the Doors and People test are simply sufficiently
sensitive to detect deficits in these domains, whereas the corresponding recall tasks
are not. Quraishi and Frangou (2002) concluded that the evidence for a non-verbal
memory deficit in bipolar patients in remission is rather contradictory and appears
to be dependent on the tests employed in its investigation.
Deficits in executive function were less pronounced in the bipolar group than in the
schizophrenia group, although slower performance on both trials of the Hayling
Sentence Completion Test would indicate impairment of basic initiation speed.
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However, the bipolar group did not differ from controls on the number of errors
made, so patients were able to suppress incorrect responses, again performing in a
similar fashion to that of the schizophrenia sample. The bipolar group did not
appear to be impaired on the Brixton test relative to controls, which would suggest
that this group of patients does not suffer from the reactive inflexibility seen in the
schizophrenia group. However, it may be that with a larger sample, such deficits
may have been apparent. Executive function deficits are not a universal finding in
remitted bipolar disorder. The deficits observed by Rubinsztein et al. (2000) in a
relatively small sample of stringently defined remitted bipolar patients, including a
relatively specific memory impairment with some recovery of function on
executive tasks, were similar to those described here.
The bipolar patients were impaired on aspects on Verbal Fluency, to a certain
extent supporting previous findings from Ferrier et al. (1999) and also interestingly
showing a similar pattern of deficits to the schizophrenia group in that they had
more difficulty in generating words in the category as opposed to the letter
condition, which again may suggest disorganisation of the semantic store rather
than simple search and retrieval difficulties. However, Ferrier et al. suggested that
residual impairments in bipolar affective disorder were specific to executive
function, a suggestion not supported by the findings of this study. On the other
hand, Clark et al. (2002) found intact performance in executive function tasks in
euthymic bipolar disorder patients, instead finding deficits in sustained attention.
One must be wary, however, of interpreting the pattern of impairments due to the
overlap between cognitive functions assessed by different neuropsychological
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tests. Executive function by definition involves the deployment and regulation of
other cognitive functions, so specific tests rely on other functions being intact.
Similarly, performance on neuropsychological tests generally relies on executive
function to a greater or lesser degree. Indeed, conscious remembering (recall and
recognition memory) engages some attentional resources, as some cognitive effort
is required to recognised or recall specific items as being 'remembered'.
The similarity of deficits between the bipolar affective disorder and schizophrenic
groups supports previous studies that fail to distinguish between these two types of
patient groups. Hoff et al. (1990) showed that deficits in verbal, spatial and speed
variables were not specific to schizophrenia but were also measured in patients
with mania. Krabbendam et al. (2000) found that outpatients with bipolar disorder
in remission had a similar pattern of impairments when directly compared with a
schizophrenia group, one of the few studies to do so, including deficits in memory,
speed of information processing and cognitive flexibility, although impairments in
the bipolar group were generally less severe than those observed in the
schizophrenia group. The schizophrenia and bipolar groups in this study were not
really differentiated by the measures used apart from increased executive
dysfunction in the schizophrenia group. This would suggest schizophrenia and
bipolar affective disorder share many features and may involve similar
dysfunctions. Nasrallah (1991) has argued that bipolar disorder is characterised by
structural brain changes similar to those in schizophrenia, which in both disorders
may have a neurodevelopmental origin.
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Performance on cognitive measures did not significantly correlate with measures of
symptom severity or years of illness. Although symptom severity scores were not
statistically controlled for in this study, the mean scores are very low.
Previous studies of residual cognitive deficits in bipolar disorder have been
criticised for failing to measure depressive or manic symptomatology and thus
subclinical psychopathology may partially account for these persistent deficits
(Murphy and Sahakian 2001). However, Rubensztein et al. (2000) conducted a
study notable for its rigorous recruitment of asymptomatic patients with bipolar
disorder and found deficits in tests of visuospatial recognition memory and
relatively spared executive functioning, concluding that bipolar disorder is
characterised by a trait abnormality in temporal lobe functioning.
The clear differences in performance of the unipolar and bipolar affective disorder
groups suggests that depression is a heterogeneous condition and the distinction
between unipolar and bipolar disorder may have a sound biological basis.
However, some cases of unipolar depression may be part of the bipolar spectrum
and this is well-illustrated in the study of the extended bipolar kindred (Family 22).
"Bipolar spectrum" is a term used to define a subgroup of patients with unipolar
depression who are likely to develop bipolar disorder (i.e. to have a manic episode)
at some future stage in their illness. Patients classified as "bipolar spectrum"
include 1) those with first or second degree relatives with bipolar illness, 2)
unipolar patients who have brief (less than four days) episodes of hypomanic
symptoms or these symptoms only in response to antidepressant medication. By
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definition all patients with unipolar depression in Family 22 belong in the category
"bipolar spectrum" and these did show impaired cognitions.
9.5 Effects of medication on cognitive performance
There is some debate in the literature as to the strength of any effect medication
may have on cognitive performance. Lithium was the main area of concern in this
study as large numbers of patients were maintained on it. Some studies have
demonstrated cognitive impairment as a result of medication (Kocsis et al. 1993)
whereas others have found no such impairment. Engelsmann et al. (1988)
followed up a cohort of patients treated with lithium over a six-year period and
found a stable cognitive performance among the sample. This is supported by the
present study, finding no statistically significant differences between patients
treated with lithium and those not.
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9.6 Cognitive changes in Family 22 haplotype carriers
The results of this study support the hypothesis that family members who carry the
haplotype linked to illness and are thus identified as being at very high risk of
developing bipolar illness show cognitive deficits similar to those observed in the
bipolar patient group. In practically all the measures showing differences between
the bipolar and control groups the "high risk" Family 22 group showed significant
differences or trends towards significance. The analysis of the family data when
partitioned into affected and unaffected haplotype carriers shows that the
unaffected group had the same range of deficits as those with symptoms.
Importantly, no differences were observed in a direct comparison of the affected
and unaffected haplotype carriers. This suggests that neuropsychological
impairment may be a useful approach to studying the genetic basis of affective
disorders and the segregation of illness in families. Cognitive changes could be
termed "endophenotypes" in bipolar disorder. Almasy and Blangero (2001) have
commented that the term "endophenotype" seems to be used only in the field of
psychiatric genetics and is used to mean a trait that is hopefully more directly
connected to the underlying neuropathology than the clinical symptoms. In order
to be considered an endophenotype, the trait should be correlated with disease but
not due to medication or degeneration due to the disease process. Furthermore,
unaffected relatives of an affected individual should show a similar, but perhaps
milder, profile. As Almasy and Blangero (2001) state, the next step is to validate
these endophenotypes and their relationship to psychiatric illness by studying them
in affected individuals and their relatives, as is the case in the present study. Once
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the relationship between the endophenotype and the psychiatric illness is
established, the next step is to attempt to localise the genes influencing the
endophenotype and hopefully then to identify biological pathways involved in
producing risk for developing psychiatric illness. Psychiatric diagnoses rely
almost entirely on symptoms reported by the patient and therefore have limited
reliability. An ideal endophenotype is an objective, biologically based marker for a
disease such as bipolar disorder in the same way as blood glucose measurement
detects diabetes.
Leboyer et al. (1998) remarked that the early enthusiasm for molecular genetic
contributions to the understanding of psychiatric illness had waned somewhat
when attempts to replicate linkage for major psychiatric disorders such as
schizophrenia and bipolar disorder met with mixed success. This slow progress
may be partly because advances in the technology of molecular biology and
genetic epidemiology have not been matched by progress in accurate, reliable and
valid phenotypic description. Psychiatrists rely on clinical symptoms and
diagnostic schemes that have no clear biological validity. Leboyer et al. (1998)
therefore posed the question: do modern definitions of clinical syndromes
(phenotypes) accurately reflect underlying genetic substrates (genotypes)? The
answer they came up with was no and one example is the lack of complete
concordance for bipolar disorder in monozygotic twins. In this case cognitive
impairment is a better way to diagnose illness than reliance on symptoms alone
because a study by Gourovitch et al. (1999) of monozygotic twins discordant for
bipolar disorder found deficits in verbal memory in the unaffected co-twins as well
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as the bipolar probands. Neuropsychological impairment may make it possible to
distinguish high and low risk relatives of bipolar individuals. The identification of
phenotypes in unaffected relatives who carry vulnerability genes may be useful in
identifying common alleles with non-specific and moderate effects on disease risk.
It is clear that understanding the genetic basis of psychiatric illness requires
accurate description of the inherited phenotype. This study was designed to
determine whether or not "high risk" but asymptomatic relatives in Family 22 had
cognitive deficits similar to those found in bipolar disorder. In other words, can
neuropsychological impairment be considered a possible endophenotype for
bipolar disorder? At this stage, the endophenotype would then be useful in
attempts to localise the gene(s) implicated in bipolar affective disorder, rather than
in specifically predicting which family members would go on to develop the
disorder. To be valuable in bipolar research it is not essential that an
endophenotype can be used in place of symptoms to reach a diagnosis. The data
from this study show for the first time that totally asymptomatic high risk
individuals have cognitive deficits and these are endophenotypes that deserve
further investigation, as they are likely to generate new hypotheses about the
pathogenesis of affective disorders. As there is overlap of results with controls, the
cognitive test results from this study will not be useful "diagnostic" markers to
distinguish cases from controls. For that one would need to identify a biological
variable where the difference between cases and controls is much greater.
Phenotypes in bipolar disorder have been less studied than they have been in
schizophrenia where neurophysiological and neuropsychological tests are well
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established (Blackwood 2001). The findings of this study supported the report by
Gourovitch et al. (1999) in showing that unaffected high risk relatives of bipolar
patients performed worse than controls on measures of verbal learning and
memory and word generation. This suggests that in bipolar disorder, some
cognitive deficits are related to symptoms or course of illness, but deficits in verbal
leaning and memory are independent of symptoms and may have a genetic basis.
9.7 Conclusions
The results of this study show that performance on cognitive tests differentiates
between controls and unipolar depressed patients on the one hand and
schizophrenic and bipolar affective disorder patients on the other. These changes
were not due to age, sex, IQ, symptomatology at time of testing or medication.
The results suggest that the relationship between schizophrenia and bipolar
disorder may be closer than that between bipolar and unipolar affective disorders.
The findings also agree with Ferrier and Thompson (2002) who suggest that the
cognitive profile of bipolar disorder is characterised by deficits in memory,
executive function or a combination of the two. The interpretation of these results
must remain somewhat speculative, but they are in keeping with an impairment of
the neuroanatomical connections between the prefrontal cortex and temporo-limbic
circuit and the family "high risk" study suggests the cause has a genetic basis.
This work investigated cognitive abilities on neuropsychological tasks using
neutral materials. The exclusion of material emotionally relevant to bipolar
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affective disorder means that the possible relationship between mood and cognition
in bipolar affective could not be investigated. Further work would benefit from
incorporating affective material into the experimental design.
The fact that both affected and unaffected haplotype carriers from Family 22 were
differentiated from the control group in measures of verbal learning and memory
suggests that mild deficits in these domains may be a biological marker of risk for
at least one genetic form of bipolar disorder. The finding that bipolar patients
experience continuing problems with memory and to some extent executive
function, and that a similar, although milder, deficits can be observed in "high risk"
relative suggests that an approach utilising neuropsychological performance an as
endophenotype may be useful for future genetic studies investigating the aetiology
of this disorder, similar to the approach used in schizophrenia. Ferrier and
Thompson (2002), in reviewing recent findings in bipolar disorder, state that
cognitive dysfunction in bipolar disorder represents an important marker for future
neurobiological and pharmacological research. More research should address the
question of whether early diagnosis and treatment could reduce the cognitive
dysfunction associated with the illness. Although unique, the family size in this
study was relatively small and future work should be extended to investigate
neuropsychological function in other large families multiply affected with major
mental illness linked to a genetic marker in order to establish to replicability and
applicability of these findings. A further interesting area of research would be to
combine neuroimaging with cognitive assessment in families to establish whether
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Numbers of schizophrenic, bipolar and unipolar patients and Family 22 members









Antidepressants 9 10 37 4
Antipsychotics 21 15 6 0
Anticonvulsants 1 2 0 0
Lithium 1 14 4 1
Sedatives 3 2 6 0
No medication 4 7 3 11
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